FeatureID,Name,Formula,MW,KEGG.Pathways,name4plot,C,H,O,NA.,F,N,Cl,P,S,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature0460,"[Similar to: 2-(2-thienyl)-1,3-thiazole-4-carboxylic acid; ΔMass: -38.9050 Da]",NA,172.07118,NA,"[Similar to: 2-(2-thienyl)-1,3-thiazole-4-carboxylic acid; ΔMass: -38.9050 Da]-peak2",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,18.18856588,28.16497583,1.548498987,0.630870439,0.00114163,0.004867417,Upregulated
Feature0293,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,3,0,0,0,0,0,0,1.2,0.3,-0.6,77.4,5,2,0.285714286,0.411764706,2,Phenol,19.01241034,29.01243889,1.525973739,0.609730134,2.39E-05,4.24E-04,Upregulated
Feature0103,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,4,0,0,0,0,0,0,1,0.4,-0.2,66,6,2,0.333333333,0.5,2,Phenol,20.21135602,30.77437718,1.522628029,0.606563541,3.73E-06,1.21E-04,Upregulated
Feature0036,NA,NA,188.06609,NA,Feature0036,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,18.8601451,28.60642439,1.51676587,0.600998407,4.99E-04,0.002860014,Upregulated
Feature0039,NA,NA,792.22295,NA,Feature0039,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,17.25646394,25.94952586,1.50375685,0.58857131,4.08E-07,3.61E-05,Upregulated
Feature0347,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,12,0,0,2,0,0,0,1.92,0.48,-0.72,80.82,3,-9,-1,-0.294117647,-11,Protein,19.47825075,29.2580094,1.502086084,0.586967496,4.10E-04,0.002508956,Upregulated
Feature0064,NA,NA,376.259,NA,Feature0064,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,18.94843484,27.93802475,1.474423877,0.560151339,0.001114502,0.004788877,Upregulated
Feature0548,NA,C14 H10 F N O2,243.07186,NA,Feature0548,14,10,2,0,1,1,0,0,0,0.714285714,0.142857143,-0.214285714,66.40714286,10.5,8.5,0.681818182,0.708333333,7.5,Condensed HC,19.06760127,28.03615059,1.470355405,0.556164917,0.010483801,0.02261212,Upregulated
Feature0479,[Similar to: (±)5(6)-DiHET; ΔMass: -166.1745 Da],NA,172.07118,NA,[Similar to: (±)5(6)-DiHET; ΔMass: -166.1745 Da],0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,18.83873407,27.41810375,1.455411157,0.541426775,1.40E-06,7.01E-05,Upregulated
Feature0541,NA,C14 H10 F N O2,243.07186,NA,Feature0541,14,10,2,0,1,1,0,0,0,0.714285714,0.142857143,-0.214285714,66.40714286,10.5,8.5,0.681818182,0.708333333,7.5,Condensed HC,18.79620442,27.25153816,1.449842615,0.535896299,8.24E-09,4.53E-06,Upregulated
Feature0515,NA,C12 H15 N3 S,233.10278,NA,Feature0515,12,15,0,0,0,3,0,0,1,1.25,0,-0.333333333,69.8,7,7,0.375,0.375,3,Unsaturated HC,18.7364087,27.15746497,1.449448792,0.535504365,1.07E-04,0.00108325,Upregulated
Feature0042,NA,NA,243.07186,NA,Feature0042,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,18.95991215,27.44375126,1.447461942,0.533525416,1.98E-05,3.89E-04,Upregulated
Feature0459,"[Similar to: 2-(2-thienyl)-1,3-thiazole-4-carboxylic acid; ΔMass: -38.9050 Da]",NA,172.07118,NA,"[Similar to: 2-(2-thienyl)-1,3-thiazole-4-carboxylic acid; ΔMass: -38.9050 Da]-peak1",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,18.71133339,27.06202355,1.446290491,0.53235735,0.002550862,0.007751237,Upregulated
Feature0304,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,6,0,0,1,0,0,0,1.888888889,0.666666667,-0.222222222,66.63333333,2,-4,-2.5,-0.4,-5,Amino Sugar,18.76405163,26.71461898,1.42371272,0.509658065,2.23E-05,4.09E-04,Upregulated
Feature0490,"?,?'-diglycerol",C6 H14 O5,166.08414,NA,"?,?'-diglycerol",6,14,5,0,0,0,0,0,0,2.333333333,0.833333333,-0.666666667,79.3,0,-5,-5,-0.714285714,-5,Carbohydrate,20.14822796,28.68429247,1.423663288,0.509607973,1.30E-04,0.001192778,Upregulated
Feature0487,(±)13-HpODE,C18 H32 O4,294.21938,Metabolic pathways;Biosynthesis of secondary metabolites;Other,(±)13-HpODE,18,32,4,0,0,0,0,0,0,1.777777778,0.222222222,-1.333333333,98.3,3,-1,-0.071428571,0.0625,-1,Lipid,19.38562057,27.38592433,1.412692683,0.498447656,0.020103588,0.038392269,Upregulated
Feature0361,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,4,0,0,7,0,0,0,1.571428571,0.571428571,2.571428571,-12.98571429,6,2,1.25,1.5,-5,Amino Sugar,18.69739707,26.3420098,1.408859731,0.494527981,0.001080758,0.004762351,Upregulated
Feature0239,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,4,0,0,0,0,0,0,1.2,0.4,-0.4,71.7,5,1,0.166666667,0.375,1,Phenol,20.58209221,28.96989351,1.40752909,0.493164739,0.00349672,0.009707994,Upregulated
Feature0461,"[Similar to: 1,4:3,6-Dianhydro-2,5-dideoxy-2-{5-[3-(dimethylamino)phenoxy]-1H-tetrazol-1-yl}-5-[(1-naphthylcarbamoyl)amino]-L-iditol; ΔMass: -343.1569 Da]",NA,158.05552,NA,"[Similar to: 1,4:3,6-Dianhydro-2,5-dideoxy-2-{5-[3-(dimethylamino)phenoxy]-1H-tetrazol-1-yl}-5-[(1-naphthylcarbamoyl)amino]-L-iditol; ΔMass: -343.1569 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,19.15121005,26.36734616,1.37679792,0.461316823,0.0020915,0.007014177,Upregulated
Feature0101,NP-019988 mzCloud,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988 mzCloud,10,10,4,0,0,0,0,0,0,1,0.4,-0.2,66,6,2,0.333333333,0.5,2,Phenol,21.22470762,29.18189748,1.374902213,0.459329014,4.91E-04,0.002842006,Upregulated
Feature0122,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,0,0,0,6,0,0,0,1,0,0.285714286,52.15714286,11,11,0.625,0.625,5,Unsaturated HC,18.61344571,25.48031165,1.368919654,0.453037773,0.003221834,0.009181392,Upregulated
Feature0210,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,2,0,0,1,0,0,0,1.857142857,0.285714286,-0.857142857,84.72857143,2,0,-0.25,0,-1,Lipid,21.1797823,28.99229699,1.368866619,0.452981879,9.90E-06,2.27E-04,Upregulated
Feature0193,ile-his,C12 H20 N4 O3,268.15357,NA,ile-his,12,20,3,0,0,4,0,0,0,1.666666667,0.25,-0.166666667,65.05,5,2,-0.4,-0.076923077,-2,Lipid,19.17029897,25.78972585,1.345295965,0.4279236,0.010258585,0.02238977,Upregulated
Feature0034,NA,NA,188.06609,NA,Feature0034,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,19.71329895,26.20441065,1.32927577,0.410640436,1.33E-04,0.001200005,Upregulated
Feature0094,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,4,0,0,0,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.333333333,0,Phenol,20.64444414,27.31722975,1.32322428,0.404057613,7.90E-04,0.003949234,Upregulated
Feature0022,RV0540000- ChemSpider,C5 H12 O4,136.07356,NA,RV0540000- ChemSpider,5,12,4,0,0,0,0,0,0,2.4,0.8,-0.8,83.1,0,-4,-4,-0.666666667,-4,Carbohydrate,19.87588704,26.21019685,1.318693188,0.399108941,0.001862025,0.006400712,Upregulated
Feature0322,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,0,0,3,0,0,0,1.615384615,0.230769231,-0.461538462,73.45384615,5,2,-0.142857143,0.058823529,-1,Lipid,19.17743162,25.25592861,1.316960952,0.39721257,0.001729359,0.005983398,Upregulated
Feature0211,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,3,0,0,1,0,0,0,2.142857143,0.428571429,-0.857142857,84.72857143,1,-2,-1,-0.333333333,-3,Protein,22.54777099,29.66103459,1.315475246,0.395584101,1.35E-05,2.87E-04,Upregulated
Feature0243,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,3,0,0,0,0,0,0,1.666666667,0.5,-0.666666667,79.3,2,-1,-0.333333333,0.111111111,-1,Protein,20.34841544,26.73270558,1.313748761,0.393689404,2.13E-04,0.001649679,Upregulated
Feature0272,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,0,0,0,1,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258065,0.532258065,16.5,Unsaturated HC,20.03263345,26.27483454,1.311601623,0.391329592,5.56E-05,6.65E-04,Upregulated
Feature0216,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,4,0,0,6,0,0,1,1.636363636,0.363636364,0.909090909,34.39090909,6,2,#NAME?,-1.5,-5,Protein,19.98037766,26.07360664,1.304960651,0.384006305,0.0010591,0.004762351,Upregulated
Feature0544,NA,C14 H10 F N O2,221.08991,Metabolic pathways;ABC transporters;Other,Feature0544,14,10,2,0,1,1,0,0,0,0.714285714,0.142857143,-0.214285714,66.40714286,10.5,8.5,0.681818182,0.708333333,7.5,Condensed HC,21.0748551,27.49100064,1.304445536,0.383436709,3.01E-05,4.79E-04,Upregulated
Feature0389,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,6,0,0,0,0,1,0,2.75,1.5,-1,88.8,0,-6,2.333333333,#NAME?,-7,Other,19.82853378,25.8460647,1.303478361,0.382366633,0.001574989,0.005852999,Upregulated
Feature0282,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,2,0,0,0,0,0,0,1,0.2,-0.6,77.4,6,4,0.5,0.555555556,4,Phenol,21.43458678,27.90097341,1.301680023,0.380374851,4.29E-05,6.05E-04,Upregulated
Feature0372,[Similar to: Maltitol; ΔMass: -198.0740 Da],NA,146.0579,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,[Similar to: Maltitol; ΔMass: -198.0740 Da],0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.31192961,27.69592177,1.299550171,0.378012332,9.30E-07,5.11E-05,Upregulated
Feature0177,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,3,0,0,2,0,0,0,2,0.6,0.4,48.9,2,-1,#NAME?,-1,-3,Amino Sugar,21.62447706,28.03241495,1.296327993,0.374430791,0.0016946,0.005983398,Upregulated
Feature0382,[Similar to: L-Glutamine],C5 H10 N2 O3,129.04259,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,[Similar to: L-Glutamine],5,10,3,0,0,2,0,0,0,2,0.6,0.4,48.9,2,-1,#NAME?,-1,-3,Amino Sugar,21.57695542,27.93500023,1.294668302,0.372582522,0.002116775,0.007055917,Upregulated
Feature0092,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,5,0,0,0,0,0,0,2.4,1,-0.4,71.7,0,-5,#NAME?,-1,-5,Carbohydrate,21.56269564,27.89652176,1.293739995,0.371547706,5.22E-05,6.38E-04,Upregulated
Feature0241,Cafestol,C20 H28 O3,294.21942,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Cafestol,20,28,3,0,0,0,0,0,0,1.4,0.15,-1.1,91.65,7,4,0.235294118,0.297297297,4,Phenol,21.88487679,28.31193832,1.29367593,0.371476263,0.003184838,0.009150277,Upregulated
Feature0196,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,2,0,0,6,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,21.25282238,27.46787598,1.29243427,0.370090911,1.48E-04,0.001282948,Upregulated
Feature0550,NA,C23 H38 O5,354.27704,NA,Feature0550,23,38,5,0,0,0,0,0,0,1.652173913,0.217391304,-1.217391304,94.99565217,5,0,0,0.12195122,0,Lipid,21.56423255,27.8228922,1.290233359,0.367632023,0.003135847,0.009125481,Upregulated
Feature0385,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,4,0,0,1,0,0,1,2.5,0.666666667,-0.333333333,69.8,0,-4,#NAME?,-2,-6,Other,20.63780314,26.4947998,1.283799424,0.360419819,1.82E-05,3.70E-04,Upregulated
Feature0031,NA,NA,366.11403,NA,Feature0031,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.63453686,27.724844,1.281508551,0.357843106,6.66E-06,1.83E-04,Upregulated
Feature0065,NA,NA,204.06093,NA,Feature0065,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.49348425,28.80913072,1.280776709,0.357018977,2.38E-06,8.74E-05,Upregulated
Feature0337,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,3,0,0,0,0,0,0,1.333333333,0.5,-0.333333333,69.8,3,0,0,0.333333333,0,Phenol,21.29272007,27.23933336,1.279279175,0.355331135,8.34E-07,5.09E-05,Upregulated
Feature0542,NA,C23 H38 O5,376.259,NA,Feature0542,23,38,5,0,0,0,0,0,0,1.652173913,0.217391304,-1.217391304,94.99565217,5,0,0,0.12195122,0,Lipid,20.46108247,26.11531869,1.276341011,0.352013838,1.28E-04,0.001192778,Upregulated
Feature0052,NA,NA,235.14196,NA,Feature0052,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.21762336,28.21360809,1.269875163,0.344686678,2.67E-07,2.94E-05,Upregulated
Feature0032,NA,NA,194.05553,NA,Feature0032,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.04560456,25.38528205,1.266376475,0.340706361,0.001060518,0.004762351,Upregulated
Feature0261,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,4,0,0,5,0,0,0,1.3,0.4,1,31.8,7,3,-2,0,-2,Phenol,21.49307526,27.00657669,1.256524549,0.329438858,0.043394143,0.070516591,Upregulated
Feature0087,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid,6,11,2,0,0,1,0,0,0,1.833333333,0.333333333,-0.666666667,79.3,2,0,-0.333333333,0,-1,Protein,20.46450902,25.70595005,1.256123468,0.328978278,3.00E-05,4.79E-04,Upregulated
Feature0175,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,6,0,0,0,0,0,0,2.333333333,1,-0.333333333,69.8,0,-6,#NAME?,-1,-6,Carbohydrate,24.19747983,30.15676296,1.246277016,0.317624779,1.29E-04,0.001192778,Upregulated
Feature0171,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,6,0,0,2,0,0,0,1.818181818,0.545454545,-0.181818182,65.48181818,3,-3,-1.666666667,-0.333333333,-5,Protein,21.81999295,26.81603326,1.228966175,0.297445208,4.86E-05,6.35E-04,Upregulated
Feature0100,NP-020521 mzCloud,C18 H32 O3,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,NP-020521 mzCloud,18,32,3,0,0,0,0,0,0,1.777777778,0.166666667,-1.444444444,101.4666667,3,0,0,0.090909091,0,Lipid,21.35457416,26.22918373,1.228270043,0.296627782,0.022009424,0.041598568,Upregulated
Feature0127,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,3,0,0,1,0,0,0,1.857142857,0.428571429,-0.571428571,76.58571429,2,-1,-0.666666667,-0.111111111,-2,Protein,21.14323415,25.88934859,1.224474383,0.292162592,0.001095696,0.004762351,Upregulated
Feature0115,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,0,0,1.6,0,-1.6,105.9,4,4,0.266666667,0.266666667,4,Lipid,21.41070424,26.17850593,1.222683086,0.290050512,0.004259094,0.010895357,Upregulated
Feature0407,[Similar to: 8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid],C18 H28 O3,310.21441,Metabolic pathways;Biosynthesis of secondary metabolites;Other,[Similar to: 8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid]-peak2,18,28,3,0,0,0,0,0,0,1.555555556,0.166666667,-1.222222222,95.13333333,5,2,0.133333333,0.212121212,2,Lipid,22.00115684,26.85352775,1.220550717,0.287532244,0.002784781,0.008328015,Upregulated
Feature0311,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,3,0,0,5,0,0,0,1.3,0.3,0.8,37.5,7,4,-0.5,0.142857143,-1,Phenol,21.14439825,25.80340172,1.220342212,0.287285769,0.099667751,0.142382502,Upregulated
Feature0055,NA,NA,334.21216,NA,Feature0055,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.63866419,26.32023377,1.21635206,0.282560862,0.010451381,0.02261212,Upregulated
Feature0084,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,3,0,0,4,0,0,0,1.454545455,0.272727273,0.181818182,55.11818182,6,3,-0.25,0.090909091,-1,Phenol,20.86462623,25.26982339,1.211132331,0.276356505,5.24E-04,0.002930406,Upregulated
Feature0240,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,4,0,0,0,0,0,0,0.888888889,0.444444444,0,60.3,6,2,0.4,0.571428571,2,Phenol,20.77275648,25.14541158,1.210499512,0.275602497,0.002798011,0.008328015,Upregulated
Feature0406,[Similar to: 8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid],C18 H28 O3,292.20382,Metabolic pathways;Biosynthesis of secondary metabolites;Other,[Similar to: 8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid]-peak1,18,28,3,0,0,0,0,0,0,1.555555556,0.166666667,-1.222222222,95.13333333,5,2,0.133333333,0.212121212,2,Lipid,21.38723558,25.8248232,1.207487668,0.272008454,2.72E-04,0.001971508,Upregulated
Feature0463,[Similar to: 1-methyl-3-phenyl-1H-pyrazol-5-amine; ΔMass: 115.9834 Da],C9 H18 N5 P3,289.07872,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,[Similar to: 1-methyl-3-phenyl-1H-pyrazol-5-amine; ΔMass: 115.9834 Da],9,18,0,0,0,5,0,3,0,2,0,-2,117.3,5,5,-3,-3,-3,Lipid,21.76602848,26.18695265,1.2031112,0.266769993,4.07E-06,1.24E-04,Upregulated
Feature0181,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,4,0,0,2,0,0,1,2,0.571428571,0.285714286,52.15714286,2,-2,#NAME?,-1.5,-5,Amino Sugar,21.82034763,26.1247077,1.197263588,0.259740809,1.40E-04,0.001241523,Upregulated
Feature0016,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,2,0,0,0,0,0,0,1.6,0.4,-0.8,83.1,2,0,0,0.25,0,Protein,21.23455203,25.41875164,1.197046757,0.259479505,0.001225281,0.005104854,Upregulated
Feature0200,Glycyl-L-leucine isomer,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine isomer,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,20.32544852,24.16881642,1.189091419,0.249859636,0.160577383,0.221347269,Upregulated
Feature0319,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,0,0,0,1,0,0,0,1.761904762,0,-1.619047619,106.4428571,4,4,0.15,0.15,3,Lipid,22.06932979,26.18977376,1.186704535,0.246960779,0.236537108,0.301845497,Upregulated
Feature0373,[Similar to: Maduramicin; ΔMass: -542.2962 Da],C18 H34 N2 O6,374.24339,NA,[Similar to: Maduramicin; ΔMass: -542.2962 Da],18,34,6,0,0,2,0,0,0,1.888888889,0.333333333,-0.888888889,85.63333333,3,-3,-0.5,-0.153846154,-5,Protein,21.60090339,25.62292112,1.186196737,0.246343308,4.35E-05,6.05E-04,Upregulated
Feature0266,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20383,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,3,0,0,0,0,0,0,1.555555556,0.166666667,-1.222222222,95.13333333,5,2,0.133333333,0.212121212,2,Lipid,22.19166192,26.30744356,1.185465228,0.245453347,0.001923466,0.006530287,Upregulated
Feature0549,NA,NA,684.19664,NA,Feature0549,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.11177737,26.00834481,1.176221358,0.234159593,0.03851437,0.064779521,Upregulated
Feature0107,NP-014287,C18 H32 O3,318.21712,NA,NP-014287,18,32,3,0,0,0,0,0,0,1.777777778,0.166666667,-1.444444444,101.4666667,3,0,0,0.090909091,0,Lipid,22.06741929,25.89039569,1.173240756,0.230499093,7.56E-06,1.98E-04,Upregulated
Feature0410,[Similar to: 6-Aminocaproic acid],C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",[Similar to: 6-Aminocaproic acid]-peak1,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,20.95445777,24.57666446,1.172860912,0.230031937,0.005367861,0.012892243,Upregulated
Feature0398,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,6,0,0,1,0,0,0,2.428571429,0.857142857,-0.285714286,68.44285714,0,-6,#NAME?,-1.333333333,-7,Carbohydrate,20.85481696,24.36652348,1.168388269,0.224519778,0.013021436,0.026723096,Upregulated
Feature0133,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide",C8 H11 N O4,185.06883,NA,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide",8,11,4,0,0,1,0,0,0,1.375,0.5,0,60.3,4,0,-0.333333333,0.2,-1,Phenol,21.5964784,25.20240961,1.166968482,0.222765596,0.005194832,0.012586598,Upregulated
Feature0280,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,4,0,0,0,0,0,0,2,0.8,-0.4,71.7,1,-3,-3,-0.333333333,-3,Carbohydrate,23.40380497,27.30799456,1.166818583,0.222580269,3.87E-04,0.002501763,Upregulated
Feature0202,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,6,0,0,0,0,1,0,3,2,-0.666666667,79.3,0,-6,1.75,4,-7,Other,22.99553513,26.6949618,1.160875868,0.215213713,0.001599576,0.005904474,Upregulated
Feature0323,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,3,0,0,0,0,0,0,1.6,0.2,-1.2,94.5,4,1,0.083333333,0.185185185,1,Lipid,22.85228359,26.45384489,1.157601812,0.211139085,0.002460923,0.007561494,Upregulated
Feature0192,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,0,0,2,0,0,0,1.2,0.4,0.8,37.5,4,2,0,0.5,0,Phenol,22.21131316,25.67642399,1.156006572,0.2091496,0.001076851,0.004762351,Upregulated
Feature0303,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,5,0,0,1,0,0,0,1.8,0.333333333,-0.933333333,86.9,3,-2,-0.333333333,-0.043478261,-3,Protein,20.65657316,23.85692952,1.154931621,0.207807437,0.103752522,0.147833904,Upregulated
Feature0097,octadec-9-ynoic acid,C18 H32 O2,262.22971,NA,octadec-9-ynoic acid,18,32,2,0,0,0,0,0,0,1.777777778,0.111111111,-1.555555556,104.6333333,3,1,0.0625,0.117647059,1,Lipid,22.22523508,25.62336175,1.152894971,0.205261089,0.005917069,0.01384846,Upregulated
Feature0251,Beauvericin,C45 H57 N3 O9,805.39159,NA,Beauvericin,45,57,9,0,0,3,0,0,0,1.266666667,0.2,-0.666666667,79.3,19,10,0.212121212,0.306666667,7,Phenol,20.37213601,23.39024354,1.148148801,0.199309629,0.028792072,0.051750456,Upregulated
Feature0053,NA,NA,318.21713,NA,Feature0053,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.12421253,25.24797756,1.141192146,0.190541722,0.005679176,0.01334849,Upregulated
Feature0206,Ergocalciferol,C28 H44 O,378.32869,NA,Ergocalciferol,28,44,1,0,0,0,0,0,0,1.571428571,0.035714286,-1.5,103.05,7,6,0.222222222,0.236363636,6,Lipid,21.23570245,24.19832076,1.139511199,0.188415103,0.199641563,0.262059332,Upregulated
Feature0045,NA,NA,283.1032,NA,Feature0045,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.11197604,24.03571279,1.13848712,0.187117969,0.002499296,0.007636737,Upregulated
Feature0165,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,0,0,1,0,0,0,2.214285714,0.071428571,-1.857142857,113.2285714,0,-1,-0.166666667,-0.12,-2,Lipid,21.06560009,23.96514903,1.137643785,0.186048897,0.38052139,0.458962203,Upregulated
Feature0138,MFCD00634809 ChemSpider,C16 H20 N2 O3,288.14736,NA,MFCD00634809 ChemSpider,16,20,3,0,0,2,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.272727273,0.36,3,Phenol,20.1977608,22.87115308,1.132360825,0.179333744,0.19919137,0.262059332,Upregulated
Feature0155,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,4,0,0,0,0,0,0,1,0.4,-0.2,66,6,2,0.333333333,0.5,2,Phenol,21.49774695,24.33961839,1.13219392,0.179121082,0.005222213,0.012597443,Upregulated
Feature0161,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,3,0,0,0,0,0,0,1.6,0.6,-0.4,71.7,2,-1,-0.5,0.142857143,-1,Amino Sugar,23.42284063,26.47416571,1.13027135,0.17666917,0.007456361,0.016876536,Upregulated
Feature0096,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,4,0,0,1,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,20.43594655,23.07366981,1.129072723,0.175138412,0.079382663,0.118078534,Upregulated
Feature0085,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,0,0,0,1,0,0,0,1.782608696,0,-1.652173913,107.3869565,4,4,0.136363636,0.136363636,3,Lipid,22.86971684,25.77855427,1.127191668,0.172732852,0.250889284,0.317216336,Upregulated
Feature0502,NA,C39 H74 N2 O6,666.55504,NA,Feature0502,39,74,6,0,0,2,0,0,0,1.897435897,0.153846154,-1.435897436,101.2230769,4,-2,-0.129032258,-0.029411765,-4,Lipid,21.41314473,24.12239413,1.126522724,0.171876416,0.353993521,0.429793459,Upregulated
Feature0236,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,4,0,0,1,0,0,1,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,25.7423676,28.97453233,1.125558176,0.170640627,0.003642085,0.009819346,Upregulated
Feature0294,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine",13,19,2,0,0,1,0,0,0,1.461538462,0.153846154,-0.923076923,86.60769231,5,3,0.2,0.272727273,2,Phenol,23.01470227,25.89259453,1.125045817,0.169983756,0.289704353,0.358868004,Upregulated
Feature0150,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,3,0,0,0,0,0,0,1.142857143,0.428571429,-0.285714286,68.44285714,4,1,0.25,0.454545455,1,Phenol,20.28520374,22.81238311,1.1245824,0.169389374,0.036731466,0.062789031,Upregulated
Feature0035,NA,NA,233.07768,NA,Feature0035,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.81159538,25.63682107,1.123850421,0.168450033,2.32E-06,8.74E-05,Upregulated
Feature0420,[Similar to: 4-Penten-1-amine],C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",[Similar to: 4-Penten-1-amine]-peak1,5,11,0,0,0,1,0,0,0,2.2,0,-1.6,105.9,1,1,0,0,0,Lipid,22.24853913,25.00401477,1.123849733,0.16844915,0.260582547,0.327964304,Upregulated
Feature0106,NP-014287 mzCloud,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287 mzCloud,18,32,3,0,0,0,0,0,0,1.777777778,0.166666667,-1.444444444,101.4666667,3,0,0,0.090909091,0,Lipid,22.75627264,25.51054002,1.121033327,0.164829168,0.006073204,0.014034714,Upregulated
Feature0057,NA,NA,246.07154,NA,Feature0057,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.59570566,24.20464865,1.120808416,0.164539694,0.017178473,0.033504113,Upregulated
Feature0402,[Similar to: Beauvericin],C45 H57 N3 O9,783.4096,NA,[Similar to: Beauvericin]-peak2,45,57,9,0,0,3,0,0,0,1.266666667,0.2,-0.666666667,79.3,19,10,0.212121212,0.306666667,7,Phenol,21.34430583,23.89870318,1.119675822,0.163081092,0.012489632,0.025824428,Upregulated
Feature0047,NA,NA,332.1964,NA,Feature0047,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.93345053,25.6734848,1.119477628,0.162825697,0.012488761,0.025824428,Upregulated
Feature0401,[Similar to: Beauvericin],C45 H57 N3 O9,800.43625,NA,[Similar to: Beauvericin]-peak1,45,57,9,0,0,3,0,0,0,1.266666667,0.2,-0.666666667,79.3,19,10,0.212121212,0.306666667,7,Phenol,20.77051531,23.12687357,1.11344727,0.155033238,0.023465667,0.043454939,Upregulated
Feature0198,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,0,0,5,0,0,0,1.909090909,0.454545455,0.363636364,49.93636364,4,-1,-6,-1,-6,Protein,22.36855336,24.87513162,1.11205813,0.153232203,4.83E-04,0.002823766,Upregulated
Feature0132,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide isomer",C8 H11 N O4,185.06882,NA,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide isomer",8,11,4,0,0,1,0,0,0,1.375,0.5,0,60.3,4,0,-0.333333333,0.2,-1,Phenol,22.25535599,24.74196382,1.11173076,0.152807437,1.79E-04,0.001470686,Upregulated
Feature0375,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17868,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak2,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,22.70958345,25.22400201,1.110720594,0.151495946,0.005971504,0.01391664,Upregulated
Feature0543,NA,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Feature0543,5,14,6,0,0,1,0,1,0,2.8,1.2,-0.8,83.1,0,-6,2.666666667,#NAME?,-8,Other,22.28356815,24.70500788,1.108664811,0.148823253,5.27E-04,0.002930406,Upregulated
Feature0015,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,8,0,0,2,0,0,0,1.818181818,0.727272727,0.181818182,55.11818182,3,-5,-7,-0.6,-7,Carbohydrate,21.75069987,24.11297008,1.10860663,0.148747541,0.039590799,0.065984664,Upregulated
Feature0180,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,2,0,0,3,0,0,1,1.666666667,0.222222222,0,60.3,4,2,-0.666666667,-0.25,-2,Lipid,22.91809231,25.33614855,1.105508618,0.144710272,0.003325153,0.009330786,Upregulated
Feature0362,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,5,0,0,9,0,0,0,1.117647059,0.294117647,1.058823529,30.12352941,13,8,-0.333333333,0.272727273,-1,Phenol,20.46792249,22.57817174,1.103100315,0.141563994,0.343118279,0.419366785,Upregulated
Feature0242,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,3,0,0,1,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.333333333,-0.185185185,-4,Lipid,22.08680984,24.32243598,1.101219966,0.139102672,0.454191208,0.53150035,Upregulated
Feature0023,NA,NA,392.30162,NA,Feature0023,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.10717052,26.54343495,1.101059742,0.13889275,0.209700569,0.273306429,Upregulated
Feature0281,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,2,0,0,0,0,0,0,1.2,0.2,-0.8,83.1,5,3,0.375,0.444444444,3,Phenol,22.29594567,24.54893032,1.101049073,0.138878771,0.070521468,0.10744268,Upregulated
Feature0403,[Similar to: AMIDINOPROLINE],C6 H11 N3 O2,157.08515,NA,[Similar to: AMIDINOPROLINE],6,11,2,0,0,3,0,0,0,1.833333333,0.333333333,0.333333333,50.8,3,1,-2,-0.5,-2,Protein,23.41024198,25.77317304,1.100935781,0.138730318,0.511821755,0.582026331,Upregulated
Feature0275,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,4,0,0,1,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,22.57495696,24.83912774,1.100295685,0.137891275,0.002372191,0.007498306,Upregulated
Feature0374,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17867,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak1,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,22.11392134,24.3106706,1.099337844,0.136634817,0.417499953,0.495950268,Upregulated
Feature0313,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,2,0,0,0,0,0,0,1.2,0.4,-0.4,71.7,3,1,0.333333333,0.5,1,Phenol,23.56978029,25.83410199,1.096068851,0.132338425,8.26E-04,0.004053956,Upregulated
Feature0329,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,2,0,0,3,0,0,0,1.666666667,0.222222222,-0.222222222,66.63333333,4,2,-0.25,0,-1,Lipid,22.99321196,25.0686954,1.090265051,0.124678906,0.002171529,0.007194825,Upregulated
Feature0343,[Similar to: Scutellarioside II; ΔMass: -306.1127 Da],NA,202.04537,NA,[Similar to: Scutellarioside II; ΔMass: -306.1127 Da]-peak1,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.61704147,26.80535854,1.088894398,0.122864046,0.412393729,0.492276193,Upregulated
Feature0112,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,3,0,0,0,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.384615385,1,Phenol,20.40876964,22.19510248,1.087527709,0.121052159,0.080505329,0.119026697,Upregulated
Feature0205,Furan,C4 H4 O,68.02622,Other,Furan,4,4,1,0,0,0,0,0,0,1,0.25,-0.5,74.55,3,2,0.666666667,0.714285714,2,Phenol,24.17823647,26.29110031,1.087387012,0.120865501,0.007433281,0.016876536,Upregulated
Feature0451,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 291.8420 Da]",NA,701.85643,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 291.8420 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.04657796,25.04138455,1.086555435,0.119761782,1.99E-04,0.001588224,Upregulated
Feature0452,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 223.8546 Da]",NA,633.86902,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 223.8546 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.1917884,25.19236216,1.08626216,0.119372327,1.11E-05,2.45E-04,Upregulated
Feature0046,NA,NA,318.21715,NA,Feature0046,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.3735875,24.29185143,1.085737878,0.118675846,2.71E-04,0.001971508,Upregulated
Feature0443,"[Similar to: 3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide]",C9 H17 N O6,235.10553,NA,"[Similar to: 3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide]",9,17,6,0,0,1,0,0,0,1.888888889,0.666666667,-0.222222222,66.63333333,2,-4,-2.5,-0.4,-5,Amino Sugar,22.17647271,24.06634858,1.085219858,0.117987353,0.016086895,0.031941489,Upregulated
Feature0204,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,5,0,0,1,0,0,0,2.166666667,0.833333333,0,60.3,1,-4,#NAME?,-1,-5,Carbohydrate,22.01696161,23.86501406,1.083937669,0.116281798,0.001370466,0.005494876,Upregulated
Feature0424,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak2",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,20.66511541,22.39063348,1.083499078,0.115697925,0.070469384,0.10744268,Upregulated
Feature0422,[Similar to: 4-Penten-1-amine],C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",[Similar to: 4-Penten-1-amine]-peak3,5,11,0,0,0,1,0,0,0,2.2,0,-1.6,105.9,1,1,0,0,0,Lipid,23.54129654,25.47957247,1.082335139,0.114147291,0.406586821,0.488097443,Upregulated
Feature0346,[Similar to: NP-022075; ΔMass: 142.0631 Da],C30 H32 O10,552.19968,NA,[Similar to: NP-022075; ΔMass: 142.0631 Da],30,32,10,0,0,0,0,0,0,1.066666667,0.333333333,-0.4,71.7,15,5,0.25,0.4,5,Phenol,20.89650773,22.6076131,1.081884753,0.113546825,0.022360823,0.041974242,Upregulated
Feature0152,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,2,0,0,1,0,0,1,2.2,0.4,-0.4,71.7,1,-1,-3,-1,-3,Protein,24.48220532,26.42875481,1.079508748,0.110374935,0.002186852,0.007202209,Upregulated
Feature0297,"3,4-Dihydroxyphenylpropionic acid",C9 H10 O4,164.04739,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other","3,4-Dihydroxyphenylpropionic acid-peak3",9,10,4,0,0,0,0,0,0,1.111111111,0.444444444,-0.222222222,66.63333333,5,1,0.2,0.428571429,1,Phenol,20.92074824,22.57071397,1.078867434,0.109517605,0.34483016,0.420524585,Upregulated
Feature0380,[Similar to: Leu-ala],C9 H18 N2 O3,202.1317,NA,[Similar to: Leu-ala]-peak2,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,22.72438473,24.49908303,1.078096649,0.108486518,0.459208175,0.535094271,Upregulated
Feature0129,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,6,0,0,1,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,22.74788318,24.4773546,1.076027796,0.105715346,0.011238114,0.023984242,Upregulated
Feature0095,Palmitic Acid,C16 H32 O2,273.2668,NA,Palmitic Acid,16,32,2,0,0,0,0,0,0,2,0.125,-1.75,110.175,1,-1,-0.071428571,0,-1,Lipid,23.58932647,25.36214031,1.07515322,0.104542272,0.606169864,0.672164164,Upregulated
Feature0516,NA,C35 H63 N O3,545.48105,NA,Feature0516,35,63,3,0,0,1,0,0,0,1.8,0.085714286,-1.542857143,104.2714286,5,2,0.032258065,0.076923077,1,Lipid,23.27750227,25.01978859,1.074848508,0.104133337,0.627580806,0.690338887,Upregulated
Feature0454,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 155.8671 Da]",NA,565.88152,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 155.8671 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.63701167,25.39691205,1.074455282,0.103605441,8.25E-06,2.06E-04,Upregulated
Feature0296,"3,4-Dihydroxyphenylpropionic acid",C9 H10 O4,164.04739,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other","3,4-Dihydroxyphenylpropionic acid-peak2",9,10,4,0,0,0,0,0,0,1.111111111,0.444444444,-0.222222222,66.63333333,5,1,0.2,0.428571429,1,Phenol,20.99890429,22.55442568,1.074076312,0.103096499,0.029146194,0.052138398,Upregulated
Feature0197,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,5,0,0,3,0,0,0,1.583333333,0.416666667,0,60.3,5,0,-0.75,-0.076923077,-3,Protein,22.59895749,24.23258036,1.072287533,0.100691815,3.54E-04,0.002320679,Upregulated
Feature0005,α-Eleostearic acid,C18 H30 O2,278.22457,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,2,0,0,0,0,0,0,1.666666667,0.111111111,-1.444444444,101.4666667,4,2,0.125,0.176470588,2,Lipid,22.73320959,24.33928193,1.070648728,0.09848522,0.015719864,0.031439728,Upregulated
Feature0184,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,3,0,0,2,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.666666667,-0.111111111,-2,Protein,23.87486804,25.53498592,1.069534117,0.096982504,0.004656584,0.011588785,Upregulated
Feature0325,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,3,0,0,0,0,0,0,1.666666667,0.166666667,-1.333333333,98.3,4,1,0.066666667,0.151515152,1,Lipid,23.03423149,24.62485532,1.069054782,0.096335783,2.45E-04,0.001822487,Upregulated
Feature0137,MFCD09839908 ChemSpider,C11 H16 N2 O3,224.11608,NA,MFCD09839908 ChemSpider,11,16,3,0,0,2,0,0,0,1.454545455,0.272727273,-0.363636364,70.66363636,5,2,0,0.2,0,Phenol,24.12421601,25.78950089,1.069029596,0.096301794,0.00109967,0.004762351,Upregulated
Feature0088,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,2,0,0,0,0,0,0,1.666666667,0.111111111,-1.444444444,101.4666667,4,2,0.125,0.176470588,2,Lipid,22.64222812,24.2018632,1.068881696,0.096102185,0.004208928,0.010817337,Upregulated
Feature0024,NA,NA,257.08995,NA,Feature0024,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.78101784,24.34486077,1.068646754,0.095785042,7.36E-04,0.003785599,Upregulated
Feature0254,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,3,0,0,5,0,0,0,2.090909091,0.272727273,-0.181818182,65.48181818,3,0,-1.666666667,-0.777777778,-5,Lipid,22.75652939,24.31700644,1.068572717,0.095685087,0.037937306,0.064004657,Upregulated
Feature0466,"[Similar to: [(1S,3R,13S,14S,17S,18R,19R,20S,21S,23R,24R,25S)-18,19,21-tris(acetyloxy)-24,25-dihydroxy-3,13,14,25-tetramethyl-6,15,22-trioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0Âa,Â?â°.0Âl,Â?Âl.0â·,ÂaÂ?]pentacosa-7(12),8,10-trien-20-yl]methyl acetate; ΔMass: -36.0466 Da]",NA,683.19594,NA,"[Similar to: [(1S,3R,13S,14S,17S,18R,19R,20S,21S,23R,24R,25S)-18,19,21-tris(acetyloxy)-24,25-dihydroxy-3,13,14,25-tetramethyl-6,15,22-trioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0Âa,Â?â°.0Âl,Â?Âl.0â·,ÂaÂ?]pentacosa-7(12),8,10-trien-20-yl]methyl acetate; ΔMass: -36.0466 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.64772115,25.26443903,1.068366752,0.095406984,0.512183171,0.582026331,Upregulated
Feature0450,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,13,0,0,0,0,3,0,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,23.95286386,25.58277844,1.068046752,0.0949748,0.002417301,0.007526464,Upregulated
Feature0125,N-alpha-Acetyllysine,C8 H16 N2 O3,188.1161,Metabolic pathways;Other,N-alpha-Acetyllysine,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,23.88901954,25.49244527,1.06711978,0.093722122,0.001524009,0.005702076,Upregulated
Feature0037,NA,NA,240.06096,NA,Feature0037,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.65022664,26.27532482,1.065926298,0.092107688,0.007748735,0.017395118,Upregulated
Feature0458,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,4,0,0,0,0,2,1,0.363636364,0.363636364,-0.363636364,70.66363636,11,7,1,1,4,Condensed HC,23.8059855,25.36721396,1.065581341,0.091640726,5.22E-05,6.38E-04,Upregulated
Feature0028,NA,NA,300.14337,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0028,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.66400243,25.20680169,1.06519604,0.091118971,4.38E-04,0.002618846,Upregulated
Feature0477,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,8,0,0,6,0,0,0,0.965517241,0.275862069,0.206896552,54.40344828,19,11,0.333333333,0.473684211,5,Phenol,20.72908331,22.06795642,1.064589113,0.090296718,0.487982999,0.561486714,Upregulated
Feature0140,MFCD00025556 ChemSpider,C8 H14 N2 O5,218.09029,NA,MFCD00025556 ChemSpider,8,14,5,0,0,2,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.428571429,-4,Amino Sugar,23.77793805,25.25915869,1.062293906,0.087182973,0.014931658,0.03036126,Upregulated
Feature0453,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,9,0,0,6,0,3,1,0.833333333,1.5,3,-25.2,9,0,0.769230769,0.647058824,-10,Other,24.66069612,26.19256672,1.062117898,0.086943918,0.004196003,0.010817337,Upregulated
Feature0214,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,4,0,0,2,0,0,0,2,0.571428571,0,60.3,2,-2,-4,-0.666666667,-4,Amino Sugar,23.51342137,24.96897027,1.061902897,0.086651848,0.022998463,0.04287849,Upregulated
Feature0074,NA,NA,566.21535,Biosynthesis of secondary metabolites;Other,Feature0074,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.05442708,22.3507053,1.061567964,0.086196739,0.353511122,0.429793459,Upregulated
Feature0455,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,13,0,0,2,0,2,0,0.8,2.6,3.6,-42.3,6,-7,0.916666667,0.818181818,-11,Other,24.41954396,25.92233938,1.061540683,0.086159663,0.002602721,0.007865364,Upregulated
Feature0514,NA,C35 H63 N O3,545.48106,NA,Feature0514,35,63,3,0,0,1,0,0,0,1.8,0.085714286,-1.542857143,104.2714286,5,2,0.032258065,0.076923077,1,Lipid,22.60355665,23.98916964,1.061300662,0.085833424,0.744907271,0.795530596,Upregulated
Feature0149,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,7,0,0,1,0,0,0,1.363636364,0.636363636,0.181818182,55.11818182,5,-2,-1,0.076923077,-3,Phenol,26.87162006,28.49609203,1.060453071,0.084680778,0.023323244,0.043337109,Upregulated
Feature0043,NA,NA,320.23285,NA,Feature0043,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.76143656,24.13731901,1.060447962,0.084673827,0.003598202,0.009797084,Upregulated
Feature0038,NA,NA,228.12221,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0038,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.64736396,25.05718294,1.059618441,0.083544857,0.002307579,0.007422038,Upregulated
Feature0429,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak7",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,21.13511503,22.38331675,1.059058194,0.082781866,0.372078923,0.450756404,Upregulated
Feature0021,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,2,0,0,0,0,0,0,1.333333333,0.333333333,-0.666666667,79.3,3,1,0.25,0.4,1,Phenol,20.65698114,21.8610008,1.058286332,0.081730019,0.032357462,0.056881772,Upregulated
Feature0212,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,4,0,0,2,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.166666667,-1,Phenol,27.23866478,28.82141266,1.058106662,0.081485065,0.032370899,0.056881772,Upregulated
Feature0425,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak3",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,21.33105707,22.51257553,1.055389588,0.077775655,0.006032153,0.013998668,Upregulated
Feature0428,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak6",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,21.01747197,22.17521917,1.055084988,0.077359214,0.330970256,0.405420135,Upregulated
Feature0501,NA,C10 H10 N2 O2,190.06944,NA,Feature0501,10,10,2,0,0,2,0,0,0,1,0.2,0,60.3,7,5,0.5,0.571428571,3,Phenol,23.75820405,25.05493027,1.054580145,0.07666874,7.34E-04,0.003785599,Upregulated
Feature0159,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,0,0,1,0,0,0,1.833333333,0.055555556,-1.555555556,104.6333333,3,2,0.0625,0.090909091,1,Lipid,23.56239401,24.82847866,1.053733277,0.075509736,4.96E-05,6.35E-04,Upregulated
Feature0478,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,10,0,0,0,0,0,0,1.066666667,0.333333333,-0.4,71.7,15,5,0.25,0.4,5,Phenol,20.79411457,21.89379853,1.052884385,0.074347026,0.046795378,0.075698405,Upregulated
Feature0230,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,10,0,0,0,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.227272727,0.37037037,5,Phenol,21.08926902,22.20365371,1.052841314,0.074288008,0.024825564,0.045665753,Upregulated
Feature0144,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,3,0,0,0,0,0,0,1,0.3,-0.4,71.7,6,3,0.428571429,0.529411765,3,Phenol,21.22579444,22.34432819,1.052696909,0.074090117,0.055442369,0.088130934,Upregulated
Feature0073,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0073,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.11688327,22.22855343,1.052643667,0.074017148,0.19235683,0.255546514,Upregulated
Feature0019,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,3,0,0,2,0,0,0,2,0.272727273,-0.909090909,86.20909091,2,-1,-0.5,-0.2,-3,Lipid,23.4827214,24.71612934,1.052524063,0.073853217,0.037438345,0.063453422,Upregulated
Feature0176,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,2,0,0,3,0,0,0,1.5,0.333333333,0.666666667,41.3,4,2,-1,0,-1,Protein,23.96983386,25.22214736,1.052245397,0.073471199,0.002229219,0.007254855,Upregulated
Feature0067,NA,NA,184.0348,NA,Feature0067,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.4190299,25.67401363,1.051393677,0.072302963,0.041808315,0.068846028,Upregulated
Feature0238,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,0,0,0,1,0,0,0,2.157894737,0,-2,117.3,0,0,-0.055555556,-0.055555556,-1,Lipid,20.81659345,21.86230519,1.050234527,0.070711531,0.172647483,0.234459545,Upregulated
Feature0059,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0059,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.46735731,22.54446417,1.050174171,0.070628619,0.075230299,0.113985301,Upregulated
Feature0170,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,3,0,0,1,0,0,0,2.333333333,1,0.666666667,41.3,1,-2,3,-3,-3,Carbohydrate,25.01555235,26.26498252,1.049946136,0.070315317,0.004205917,0.010817337,Upregulated
Feature0488,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,6,0,0,0,0,0,0,1,0.3,-0.4,71.7,11,5,0.357142857,0.470588235,5,Phenol,21.14855031,22.19242124,1.049358983,0.069508304,0.032692508,0.057263947,Upregulated
Feature0026,NA,NA,409.15857,NA,Feature0026,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.82549786,24.99704905,1.04917216,0.069251431,0.015630383,0.031439728,Upregulated
Feature0504,NA,C12 H23 N O4,245.16269,NA,Feature0504,12,23,4,0,0,1,0,0,0,1.916666667,0.333333333,-1,88.8,2,-2,-0.428571429,-0.111111111,-3,Protein,20.45955873,21.45927445,1.048863014,0.068826269,0.009620134,0.02132266,Upregulated
Feature0331,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,5,0,0,1,0,0,0,2.5,0.833333333,-0.333333333,69.8,0,-5,#NAME?,-1.4,-6,Carbohydrate,21.65485227,22.71079245,1.04876229,0.068687716,0.216631829,0.280347073,Upregulated
Feature0388,[Similar to: Glycyl-L-leucine],C8 H16 N2 O3,188.11611,Metabolic pathways;Other,[Similar to: Glycyl-L-leucine],8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,23.60791835,24.75359962,1.048529534,0.068367498,0.028319117,0.05106726,Upregulated
Feature0423,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak1",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,21.36893694,22.40289344,1.048385959,0.068169936,0.08533726,0.124167971,Upregulated
Feature0522,NA,C19 H20 N4 O2,318.1539,NA,Feature0522,19,20,2,0,0,4,0,0,0,1.052631579,0.105263158,-0.210526316,66.3,12,10,0.461538462,0.5,6,Unsaturated HC,24.22745291,25.38609054,1.047823336,0.067395498,0.001496731,0.00563837,Upregulated
Feature0456,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -252.0576 Da]",NA,157.9568,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -252.0576 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.69369932,25.868587,1.04757844,0.067058273,0.001213967,0.005098643,Upregulated
Feature0457,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,6,0,0,2,0,1,1,1,2,4,-53.7,4,-2,0.857142857,0.75,-6,Other,26.64261181,27.8963963,1.047059369,0.066343246,0.015894543,0.031673908,Upregulated
Feature0433,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,2,0,0,6,0,0,0,1.894736842,0.105263158,-0.736842105,81.3,5,3,-0.272727273,-0.166666667,-3,Lipid,25.87652115,27.09039775,1.046910348,0.066137902,0.575316514,0.644448233,Upregulated
Feature0174,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,0,0,2,0,0,0,2.333333333,0.333333333,-0.666666667,79.3,1,-1,-1.5,-0.666666667,-3,Other,24.80182837,25.96464113,1.046884155,0.066101807,0.002227423,0.007254855,Upregulated
Feature0489,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,7,0,0,0,0,0,0,2.285714286,1,-0.285714286,68.44285714,0,-7,#NAME?,-1,-7,Carbohydrate,23.2951418,24.33776114,1.044756944,0.063167347,0.540167425,0.611300583,Upregulated
Feature0040,NA,NA,276.08212,NA,Feature0040,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.98088486,23.99900434,1.044302884,0.062540204,0.034571115,0.059792808,Upregulated
Feature0334,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,2,0,0,1,0,0,0,2.142857143,0.285714286,-1.142857143,92.87142857,1,-1,-0.5,-0.2,-2,Lipid,20.08387365,20.97216376,1.044229023,0.062438162,0.085131178,0.124167971,Upregulated
Feature0378,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17868,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak5,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,23.76987443,24.80014782,1.043343662,0.061214438,0.057031149,0.089877168,Upregulated
Feature0377,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17868,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak4,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,23.76653132,24.79434509,1.043246267,0.061079759,0.056507853,0.089308389,Upregulated
Feature0436,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]",C22 H26 O7,370.14171,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]-peak2",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,21.20808198,22.10885788,1.042473237,0.060010347,0.040096555,0.066625695,Upregulated
Feature0495,NA,NA,581.85559,NA,Feature0495,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.06014179,25.07167091,1.042041694,0.059413004,8.96E-04,0.004303837,Upregulated
Feature0070,NA,NA,313.07741,NA,Feature0070,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.47663569,27.56588163,1.041139892,0.058163928,0.077155548,0.115944129,Upregulated
Feature0182,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,4,0,0,1,0,0,0,1.75,1,1,31.8,2,-2,3,-1,-3,Carbohydrate,25.87922429,26.94277833,1.041096828,0.058104254,0.016547607,0.032620731,Upregulated
Feature0029,NA,NA,318.14293,NA,Feature0029,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.31089071,25.30095172,1.040724999,0.057588902,4.49E-04,0.002652485,Upregulated
Feature0533,NA,C2 H3 P S,89.96937,NA,Feature0533,2,3,0,0,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,25.59044907,26.62817149,1.040551161,0.0573479,0.007704481,0.017366657,Upregulated
Feature0213,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,2,0,0,4,0,0,0,2.333333333,0.333333333,0.333333333,50.8,2,0,#NAME?,-3,-4,Other,26.48485759,27.55734569,1.040494388,0.057269183,0.009751162,0.021367088,Upregulated
Feature0427,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak5",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,21.12945511,21.98298366,1.040395199,0.057131647,0.130117076,0.182097689,Upregulated
Feature0290,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21536,Biosynthesis of secondary metabolites;Other,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",31,34,10,0,0,0,0,0,0,1.096774194,0.322580645,-0.451612903,73.17096774,15,5,0.238095238,0.384615385,5,Phenol,21.09006397,21.94040658,1.040319584,0.05702679,0.038997002,0.065192557,Upregulated
Feature0041,NA,NA,247.09328,NA,Feature0041,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.97579987,25.97962963,1.040192097,0.056849982,0.00373997,0.009985358,Upregulated
Feature0497,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0497,9,8,17,0,0,0,0,2,2,0.888888889,1.888888889,2.222222222,-3.033333333,7,-10,1.166666667,1.571428571,-14,Other,24.18856235,25.15129501,1.039801153,0.05630766,7.84E-04,0.003949234,Upregulated
Feature0114,NP-003459,C9 H14 O4,168.07869,Metabolic pathways;Other,NP-003459,9,14,4,0,0,0,0,0,0,1.555555556,0.444444444,-0.666666667,79.3,3,-1,-0.2,0.142857143,-1,Protein,22.55807605,23.44641633,1.039380144,0.055723403,0.065853754,0.101740351,Upregulated
Feature0439,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid; ΔMass: -46.0418 Da]",C14 H21 N4 O5 P,356.1261,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid; ΔMass: -46.0418 Da]",14,21,5,0,0,4,0,1,0,1.5,0.357142857,-0.285714286,68.44285714,7,2,-0.75,-0.076923077,-3,Protein,20.65691057,21.46903047,1.039314684,0.055632539,0.090838843,0.131477273,Upregulated
Feature0060,NA,NA,159.08957,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Feature0060,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.22251544,22.05306454,1.039135281,0.055383485,0.089481977,0.129855111,Upregulated
Feature0289,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16794,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,20.66390922,21.47030997,1.039024598,0.055229809,0.033357515,0.058058966,Upregulated
Feature0474,"[Similar to: (2S,3R,3aS,7aR)-2-(3,4-dimethoxyphenyl)-3a,7a-dimethoxy-3-methyl-5-(prop-2-en-1-yl)-2,3,3a,6,7,7a-hexahydro-1-benzofuran-6-one; ΔMass: 209.0692 Da]",C36 H41 N O3 P2,597.25775,NA,"[Similar to: (2S,3R,3aS,7aR)-2-(3,4-dimethoxyphenyl)-3a,7a-dimethoxy-3-methyl-5-(prop-2-en-1-yl)-2,3,3a,6,7,7a-hexahydro-1-benzofuran-6-one; ΔMass: 209.0692 Da]",36,41,3,0,0,1,0,2,0,1.138888889,0.083333333,-1.166666667,93.55,18,15,0.4,0.428571429,12,Unsaturated HC,20.73296549,21.53780098,1.038819121,0.054944474,0.029197503,0.052138398,Upregulated
Feature0113,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,4,0,0,0,0,0,0,1.7,0.2,-1.3,97.35,4,0,0,0.111111111,0,Lipid,22.4735217,23.32541532,1.037906548,0.05367655,0.099594957,0.142382502,Upregulated
Feature0215,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,3,0,0,0,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.230769231,-3,Protein,26.65586759,27.66277742,1.037774416,0.053492875,0.067779619,0.104422382,Upregulated
Feature0535,NA,C23 H40 N2 O3,370.31962,NA,Feature0535,23,40,3,0,0,2,0,0,0,1.739130435,0.130434783,-1.217391304,94.99565217,5,2,0,0.076923077,0,Lipid,26.25157214,27.23813384,1.037581052,0.053224039,0.018378141,0.03559147,Upregulated
Feature0493,NA,C H3 N O5,109.00137,NA,Feature0493,1,3,5,0,0,1,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,23.87516386,24.74897426,1.036599137,0.051858098,0.08398366,0.123176035,Upregulated
Feature0252,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,0,0,0,2,0,0,0,0.833333333,0,-0.333333333,69.8,9,9,0.7,0.7,7,Unsaturated HC,19.72944464,20.44821541,1.036431374,0.051624593,0.077981099,0.116547838,Upregulated
Feature0302,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,10,0,0,0,0,0,0,1.034482759,0.344827586,-0.344827586,70.12758621,15,5,0.263157895,0.416666667,5,Phenol,21.22352157,21.99276804,1.036244997,0.051365136,0.041215843,0.068279258,Upregulated
Feature0033,NA,NA,266.07009,Other,Feature0033,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.32261014,25.20403884,1.036239067,0.051356881,0.002263372,0.007322674,Upregulated
Feature0317,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,3,0,0,1,0,0,0,1.1,0.3,-0.2,66,6,3,0.333333333,0.466666667,2,Phenol,23.96136701,24.82113162,1.035881284,0.050858674,0.015702781,0.031439728,Upregulated
Feature0051,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0051,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.26960629,22.03274761,1.035879428,0.05085609,0.239987931,0.304834555,Upregulated
Feature0163,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,3,0,0,2,0,0,0,1.466666667,0.2,-0.666666667,79.3,6,3,0.1,0.217391304,1,Phenol,23.13958999,23.95069882,1.035052861,0.049704449,0.029308262,0.05216681,Upregulated
Feature0437,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]",C22 H26 O7,402.16788,NA,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]-peak3",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,20.52546833,21.24472784,1.035042295,0.049689722,0.277232704,0.344194102,Upregulated
Feature0537,NA,C12 H12 N2 O S,232.07112,NA,Feature0537,12,12,1,0,0,2,0,0,1,1,0.083333333,-0.166666667,65.05,8,7,0.5,0.529411765,4,Unsaturated HC,26.06045662,26.9415123,1.033808144,0.047968473,0.230126312,0.295033733,Upregulated
Feature0332,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,2,0,0,6,0,0,0,1.428571429,0.285714286,1.714285714,11.44285714,6,4,2,#NAME?,-2,Phenol,24.93392642,25.77095278,1.033569778,0.04763579,0.126230162,0.177108645,Upregulated
Feature0498,NA,C4 H N4 O7 P3,309.90566,NA,Feature0498,4,1,7,0,0,4,0,3,0,0.25,1.75,2.5,-10.95,8,1,0.6,0.384615385,-6,Other,24.16685648,24.97334005,1.033371472,0.047358961,0.001424551,0.005494876,Upregulated
Feature0044,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0044,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.99424213,21.69214278,1.033242478,0.047178862,0.092783519,0.133588837,Upregulated
Feature0218,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,2,0,0,1,0,0,0,1.9,0.2,-1.2,94.5,2,0,-0.142857143,0,-1,Lipid,21.49129395,22.20342095,1.033135604,0.047029627,0.052259199,0.083553953,Upregulated
Feature0093,Penicillic acid isomer 1,C8 H10 O4,170.05554,NA,Penicillic acid isomer 1,8,10,4,0,0,0,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.333333333,0,Phenol,19.54441498,20.18530455,1.032791443,0.046548953,0.202594427,0.265302226,Upregulated
Feature0509,NA,C6 H5 O13 P3,377.89309,NA,Feature0509,6,5,13,0,0,0,0,3,0,0.833333333,2.166666667,1,31.8,6,-7,1,1,-10,Other,24.64675105,25.45131838,1.032643951,0.046342908,0.003512529,0.009707994,Upregulated
Feature0178,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,4,0,0,1,0,0,0,1.8,0.8,0.4,48.9,2,-2,#NAME?,-0.5,-3,Carbohydrate,28.42761862,29.35538343,1.032636037,0.046331851,0.042101259,0.06912147,Upregulated
Feature0271,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,3,0,0,0,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.692307692,3,Condensed HC,20.29469334,20.93628003,1.03161352,0.044902586,0.021473461,0.04072553,Upregulated
Feature0435,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]",C22 H26 O7,402.16791,NA,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]-peak1",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,20.23123018,20.86782774,1.031466083,0.044696382,0.035245871,0.060768744,Upregulated
Feature0142,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,3,0,0,0,0,0,0,1.666666667,0.5,-0.666666667,79.3,2,-1,-0.333333333,0.111111111,-1,Protein,20.56427041,21.20529874,1.031171946,0.04428492,0.109090294,0.154240776,Upregulated
Feature0387,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,2,0,0,8,0,2,2,2.833333333,0.166666667,-1,88.8,1,-1,6.5,12,-13,Other,21.86594188,22.5373096,1.03070381,0.043629809,0.091595553,0.132224551,Upregulated
Feature0002,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,0,0,1,0,0,0,1.8,0.2,-0.8,83.1,2,1,0,0.142857143,0,Lipid,21.86251333,22.51126842,1.029674314,0.042188085,0.419394147,0.497126683,Upregulated
Feature0511,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0511,3,2,18,0,0,4,0,0,2,0.666666667,6,16.66666667,-414.7,5,-13,0.904761905,0.833333333,-19,Other,24.94761021,25.6758789,1.029191922,0.041512039,0.019640892,0.03763934,Upregulated
Feature0310,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,3,0,0,2,0,0,0,1.555555556,0.333333333,-0.222222222,66.63333333,4,1,-0.25,0.090909091,-1,Protein,24.96365321,25.68301662,1.028816432,0.04098559,0.053376209,0.085092507,Upregulated
Feature0358,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,8,0,0,6,0,0,0,0.888888889,0.296296296,0.37037037,49.74444444,19,11,0.384615385,0.529411765,5,Phenol,20.24735713,20.81502958,1.028036866,0.039892002,0.047886179,0.077235772,Upregulated
Feature0119,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,2,0,0,4,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,24.51119878,25.19186448,1.02776958,0.039516857,0.043463863,0.070516591,Upregulated
Feature0486,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,3,0,0,0,0,0,0,1.7,0.15,-1.4,100.2,4,1,0.058823529,0.135135135,1,Lipid,21.15255276,21.73401677,1.02748907,0.039123048,0.259894765,0.3278489,Upregulated
Feature0315,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,6,0,0,0,0,0,0,0.947368421,0.315789474,-0.315789474,69.3,11,5,0.384615385,0.5,5,Phenol,20.48822364,21.04821112,1.027332163,0.038902718,0.018735299,0.03615584,Upregulated
Feature0244,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,0,0,1,0,0,0,1.545454545,0.090909091,-1.090909091,91.39090909,4,3,0.222222222,0.263157895,2,Lipid,19.89193555,20.43255177,1.027177658,0.038685728,0.065046145,0.100775718,Upregulated
Feature0300,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,3,0,0,2,0,0,0,1.333333333,0.25,-0.333333333,69.8,6,3,0.142857143,0.294117647,1,Phenol,19.97720657,20.5178582,1.027063425,0.038525277,0.062446787,0.097021844,Upregulated
Feature0283,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,10,0,0,1,0,0,0,1.137931034,0.344827586,-0.344827586,70.12758621,14,4,0.166666667,0.347826087,3,Phenol,20.27878833,20.82142407,1.026758785,0.038097292,0.027026403,0.04904822,Upregulated
Feature0265,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,0,0,5,0,0,0,1.3,0.5,1.2,26.1,7,2,#NAME?,-0.2,-3,Phenol,26.90489776,27.62093816,1.026613756,0.037893498,0.033605726,0.058306465,Upregulated
Feature0110,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,0,0,2,0,0,0,1.636363636,0.181818182,-0.727272727,81.02727273,4,2,0,0.125,0,Lipid,25.89421194,26.58040867,1.026500005,0.037733634,0.07943465,0.118078534,Upregulated
Feature0336,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,7,0,0,0,0,0,0,1.142857143,0.333333333,-0.476190476,73.87142857,10,3,0.214285714,0.371428571,3,Phenol,21.15102018,21.70031199,1.025969991,0.036988534,0.068710482,0.105560797,Upregulated
Feature0547,NA,C8 H15 N O4,189.10013,NA,Feature0547,8,15,4,0,0,1,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,20.94363942,21.48726382,1.025956539,0.036969618,0.1602996,0.221347269,Upregulated
Feature0309,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,0,0,2,0,0,0,1.6,0.2,-0.6,77.4,4,2,0,0.142857143,0,Lipid,25.38720663,26.04230769,1.025804377,0.036755632,0.106197155,0.150537204,Upregulated
Feature0476,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,8,0,0,6,0,0,0,1,0.266666667,0.133333333,56.5,19,11,0.3125,0.45,5,Phenol,20.73994519,21.27364786,1.02573308,0.036655356,0.175392811,0.236436388,Upregulated
Feature0520,NA,C9 H11 N O3,181.07154,NA,Feature0520,9,11,3,0,0,1,0,0,0,1.222222222,0.333333333,-0.222222222,66.63333333,5,2,0.2,0.384615385,1,Phenol,21.29939361,21.84714007,1.025716528,0.036632076,0.170719262,0.232414837,Upregulated
Feature0503,NA,NA,100.00105,NA,Feature0503,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.54966196,25.17974556,1.025665673,0.036560545,0.015133146,0.030600111,Upregulated
Feature0318,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,2,0,0,6,0,0,0,1.75,0.25,1,31.8,5,3,#NAME?,-2,-3,Lipid,25.65767822,26.31311759,1.025545545,0.036391564,0.32830295,0.403952176,Upregulated
Feature0080,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,0,0,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,25.50663314,26.14952989,1.025205081,0.035912533,0.079827318,0.118342386,Upregulated
Feature0496,NA,C3 H5 N2 P S,131.99089,NA,Feature0496,3,5,0,0,0,2,0,1,1,1.666666667,0,-0.666666667,79.3,3,3,1,1,-1,Lipid,24.2939617,24.9022658,1.025039313,0.035679242,0.003578588,0.009792157,Upregulated
Feature0464,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,5,0,0,6,0,0,0,0.888888889,0.277777778,0.666666667,41.3,14,9,0.428571429,0.578947368,3,Phenol,20.04236723,20.53590632,1.02462479,0.035095702,0.04163117,0.068760191,Upregulated
Feature0058,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0058,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.10847715,21.62462253,1.024452043,0.034852449,0.043267103,0.070516591,Upregulated
Feature0139,MFCD00063043 ChemSpider,C11 H14 N2 O3,222.10044,NA,MFCD00063043 ChemSpider,11,14,3,0,0,2,0,0,0,1.272727273,0.272727273,-0.181818182,65.48181818,6,3,0.166666667,0.333333333,1,Phenol,23.30159097,23.87071737,1.024424358,0.034813462,0.832921913,0.869273344,Upregulated
Feature0146,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,3,0,0,5,0,0,0,2.111111111,0.333333333,0.222222222,53.96666667,3,0,-5,-1.4,-5,Protein,23.46604126,24.0287817,1.023981055,0.034189024,0.037495204,0.063453422,Upregulated
Feature0162,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,3,0,0,2,0,0,0,1.818181818,0.272727273,-0.727272727,81.02727273,3,0,-0.333333333,-0.066666667,-2,Lipid,26.00965953,26.62345005,1.02359856,0.033650023,0.248100756,0.314413401,Upregulated
Feature0270,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,3,0,0,2,0,0,0,1.5,0.375,0,60.3,4,1,-0.333333333,0.111111111,-1,Protein,25.35156205,25.93106581,1.0228587,0.032606862,0.097456007,0.139949879,Upregulated
Feature0169,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,3,0,0,1,0,0,0,2.25,0.75,0,60.3,1,-2,#NAME?,-1,-3,Carbohydrate,25.63073156,26.20542942,1.022422219,0.031991093,0.061425105,0.095704837,Upregulated
Feature0011,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,0,0,2,0,0,0,1,0.5,1.5,17.55,4,2,NA,1,0,Phenol,24.57422819,25.12149854,1.022270093,0.031776419,0.614757741,0.680315408,Upregulated
Feature0183,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,6,0,0,1,0,1,0,2.5,0.75,-1.25,95.925,0,-6,#NAME?,-1.666666667,-8,Carbohydrate,28.89553578,29.53279799,1.022054002,0.031471426,0.031460158,0.055636936,Upregulated
Feature0518,NA,C30 H30 N6 O9,618.20799,NA,Feature0518,30,30,9,0,0,6,0,0,0,1,0.3,0.2,54.6,19,10,0.266666667,0.435897436,4,Phenol,20.41680032,20.86623977,1.022013216,0.031413853,0.194813266,0.257609661,Upregulated
Feature0148,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,4,0,0,0,0,0,0,1.272727273,0.363636364,-0.545454545,75.84545455,5,1,0.142857143,0.333333333,1,Phenol,20.44999691,20.89114542,1.021572058,0.03079097,0.629621962,0.691201755,Upregulated
Feature0448,[Similar to: 2-Iodoamphetamine; ΔMass: -45.0581 Da],NA,215.94331,NA,[Similar to: 2-Iodoamphetamine; ΔMass: -45.0581 Da],0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.4319934,25.97888166,1.021503948,0.03069478,0.069455147,0.106407607,Upregulated
Feature0233,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,0,0,2,0,0,0,1.142857143,0.142857143,-0.428571429,72.51428571,8,6,0.4,0.454545455,4,Phenol,26.38794628,26.9552935,1.021500241,0.030689545,0.135058883,0.188533974,Upregulated
Feature0006,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,3,0,0,2,0,0,0,1.8,0.3,-0.6,77.4,3,0,-0.4,-0.076923077,-2,Lipid,25.27811221,25.81895536,1.02139571,0.030541904,0.198507034,0.26181983,Upregulated
Feature0260,Adenosine isomer,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine isomer,10,13,4,0,0,5,0,0,0,1.3,0.4,1,31.8,7,3,-2,0,-2,Phenol,26.48863674,27.0438107,1.020958948,0.029924857,0.819936195,0.862265597,Upregulated
Feature0534,NA,C19 H20 N4 O2,336.16458,NA,Feature0534,19,20,2,0,0,4,0,0,0,1.052631579,0.105263158,-0.210526316,66.3,12,10,0.461538462,0.5,6,Unsaturated HC,25.27001192,25.79266206,1.020682623,0.029534336,0.082189239,0.121190567,Upregulated
Feature0536,NA,C11 H20 N4 O3,256.15356,NA,Feature0536,11,20,3,0,0,4,0,0,0,1.818181818,0.272727273,-0.181818182,65.48181818,4,1,-0.75,-0.272727273,-3,Lipid,18.89068399,19.2805416,1.020637559,0.029470639,0.024267417,0.044788857,Upregulated
Feature0014,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,3,0,0,2,0,0,0,1.466666667,0.2,-0.666666667,79.3,6,3,0.1,0.217391304,1,Phenol,23.63488287,24.12164834,1.020595214,0.029410781,0.235815787,0.301624843,Upregulated
Feature0530,NA,NA,101.96297,NA,Feature0530,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.76575907,26.27922769,1.019928333,0.028467782,0.076782903,0.115700265,Upregulated
Feature0449,[Similar to: 2-Iodoamphetamine; ΔMass: -27.0476 Da],NA,233.95388,NA,[Similar to: 2-Iodoamphetamine; ΔMass: -27.0476 Da],0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.84768267,26.34483183,1.0192338,0.027485027,0.104813376,0.148959579,Upregulated
Feature0505,NA,C18 H15 N3 O,289.11625,NA,Feature0505,18,15,1,0,0,3,0,0,0,0.833333333,0.055555556,-0.222222222,66.63333333,13,12,0.642857143,0.655172414,9,Unsaturated HC,22.52801303,22.95808563,1.01909057,0.027282274,0.302902212,0.37437352,Upregulated
Feature0298,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,3,0,0,0,0,0,0,1.6,0.6,-0.4,71.7,2,-1,-0.5,0.142857143,-1,Amino Sugar,23.43578714,23.88307611,1.019085724,0.027275415,0.620233549,0.684996892,Upregulated
Feature0134,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,0,0,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.638888889,0.666666667,11.5,Condensed HC,21.61627963,22.02721726,1.019010562,0.027169005,0.168315278,0.229710677,Upregulated
Feature0208,DL-Tryptophan isomer 1,C11 H12 N2 O2,187.06332,Microbial metabolism in diverse environments;Other,DL-Tryptophan isomer 1,11,12,2,0,0,2,0,0,0,1.090909091,0.181818182,-0.181818182,65.48181818,7,5,0.428571429,0.5,3,Phenol,27.40365895,27.91672604,1.018722576,0.026761223,0.218907393,0.282626916,Upregulated
Feature0277,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,3,0,0,1,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,21.53373708,21.93140528,1.018467217,0.026399543,0.157320638,0.217950506,Upregulated
Feature0209,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,0,0,2,0,0,0,1.090909091,0.181818182,-0.181818182,65.48181818,7,5,0.428571429,0.5,3,Phenol,27.53028326,28.03746017,1.018422509,0.026336212,0.227060543,0.291783408,Upregulated
Feature0264,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,2,0,0,1,0,0,0,1.545454545,0.181818182,-0.909090909,86.20909091,4,2,0.125,0.222222222,1,Lipid,19.89525463,20.25894642,1.018280328,0.026134784,0.430813268,0.507381793,Upregulated
Feature0312,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,3,0,0,5,0,0,0,1.3,0.3,0.8,37.5,7,4,-0.5,0.142857143,-1,Phenol,25.67640733,26.14011318,1.018059608,0.025822034,0.773664005,0.818300933,Upregulated
Feature0234,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,0,0,2,0,0,0,1.636363636,0.181818182,-0.727272727,81.02727273,4,2,0,0.125,0,Lipid,26.85310452,27.33792748,1.018054634,0.025814985,0.212297591,0.275740944,Upregulated
Feature0291,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,2,0,0,0,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.333333333,2,Phenol,22.71689793,23.10165867,1.016937204,0.024230596,0.330393114,0.405420135,Upregulated
Feature0539,NA,C4 H2 O8 S2,241.91814,NA,Feature0539,4,2,8,0,0,0,0,0,2,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,26.36515654,26.78919403,1.016083253,0.023018615,0.161860458,0.222003121,Upregulated
Feature0356,[Similar to: NP-013538; ΔMass: 86.0004 Da],C15 H18 O11,374.08493,NA,[Similar to: NP-013538; ΔMass: 86.0004 Da],15,18,11,0,0,0,0,0,0,1.2,0.733333333,0.266666667,52.7,7,-4,-1,0.157894737,-4,Other,20.01732575,20.33847045,1.016043337,0.022961938,0.0483339,0.077729955,Upregulated
Feature0292,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,3,0,0,1,0,0,0,2.111111111,0.333333333,-1.111111111,91.96666667,1,-2,-0.6,-0.230769231,-3,Protein,22.12027193,22.46785966,1.015713538,0.022493575,0.267593758,0.334492198,Upregulated
Feature0237,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,0,0,1,0,0,0,2.6,0.2,-1.6,105.9,0,-1,-0.666666667,-0.428571429,-2,Other,29.30922669,29.74950374,1.01502179,0.021510699,0.109888049,0.154970325,Upregulated
Feature0545,NA,NA,85.98542,NA,Feature0545,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.74586844,27.13131455,1.014411426,0.020642901,0.239985898,0.304834555,Upregulated
Feature0154,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,0,0,1,0,0,0,1.363636364,0.090909091,-0.909090909,86.20909091,5,4,0.333333333,0.368421053,3,Unsaturated HC,20.45871595,20.73319615,1.013416296,0.019226934,0.379604878,0.458863039,Upregulated
Feature0540,NA,NA,103.99596,NA,Feature0540,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.90249211,27.25685584,1.013172153,0.01887933,0.191951267,0.255546514,Upregulated
Feature0118,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,1,0,0,3,0,0,0,2.333333333,0.111111111,-1.111111111,91.96666667,1,0,-0.6,-0.454545455,-3,Lipid,20.76759251,21.02569182,1.012427984,0.01781929,0.481985383,0.555748345,Upregulated
Feature0438,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]",C22 H26 O7,402.1679,NA,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]-peak4",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,20.87032908,21.12153389,1.012036457,0.017261261,0.764040482,0.811239894,Upregulated
Feature0426,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak4",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,21.79597797,22.0451784,1.011433322,0.016401214,0.670627949,0.721408082,Upregulated
Feature0327,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,5,0,0,0,0,0,1,2.333333333,0.833333333,-0.333333333,69.8,0,-5,#NAME?,-1.4,-6,Carbohydrate,22.58855505,22.82354786,1.01040318,0.014931085,0.572102437,0.643468999,Upregulated
Feature0314,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,5,0,0,2,0,0,0,1.8,0.5,-0.2,66,3,-2,-1.333333333,-0.272727273,-4,Protein,23.61431372,23.8494043,1.009955427,0.014291623,0.493527322,0.565500057,Upregulated
Feature0405,"[Similar to: 9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one]",C11 H17 N O2,195.12596,NA,"[Similar to: 9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one]",11,17,2,0,0,1,0,0,0,1.545454545,0.181818182,-0.909090909,86.20909091,4,2,0.125,0.222222222,1,Lipid,20.09060577,20.28116024,1.009484755,0.013619123,0.792319223,0.836421445,Upregulated
Feature0473,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,3,0,0,0,0,3,0,1.727272727,0.272727273,-2.545454545,132.8454545,4,1,-0.4,-0.076923077,-2,Lipid,20.37574683,20.55294606,1.008696576,0.012492265,0.764019843,0.811239894,Upregulated
Feature0485,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,4,0,0,0,0,0,0,0.8,0.8,0.8,37.5,4,0,0,0.666666667,0,Condensed HC,25.15215766,25.36783737,1.008574998,0.012318368,0.0596904,0.093266249,Upregulated
Feature0269,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,4,0,0,0,0,0,0,1.142857143,0.571428571,0,60.3,4,0,0,0.4,0,Phenol,20.72309254,20.89383244,1.008239113,0.011837828,0.650920232,0.706126485,Upregulated
Feature0510,NA,C18 H19 F3 N2,283.12969,NA,Feature0510,18,19,0,0,3,2,0,0,0,1.055555556,0,-0.722222222,80.88333333,10.5,10.5,0.53125,0.53125,8.5,Unsaturated HC,19.43175507,19.58166908,1.007714898,0.01108753,0.19484658,0.257609661,Upregulated
Feature0462,"[Similar to: 1,2,3-Tris({4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl}methyl) 2-hydroxypropane-1,2,3-tricarboxylate; ΔMass: -782.3022 Da]",NA,214.00891,NA,"[Similar to: 1,2,3-Tris({4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl}methyl) 2-hydroxypropane-1,2,3-tricarboxylate; ΔMass: -782.3022 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,28.21618019,28.42784998,1.007501717,0.010782297,0.421544134,0.498600589,Upregulated
Feature0521,NA,C11 H11 N3 O S,233.0664,NA,Feature0521,11,11,1,0,0,3,0,0,1,1,0.090909091,0.181818182,55.11818182,8,7,0.5,0.538461538,3,Unsaturated HC,24.36547192,24.54089882,1.007199815,0.010349924,0.514941487,0.583954264,Upregulated
Feature0390,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,4,0,0,2,1,0,1,1.25,1,2.75,-18.075,3.5,-0.5,1.166666667,1.5,-3.5,Other,25.78069659,25.95743031,1.006855273,0.009856323,0.582527505,0.650185966,Upregulated
Feature0391,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,5,0,0,2,1,0,1,1.75,1.25,2.75,-18.075,2.5,-2.5,1.375,2,-5.5,Carbohydrate,26.84998186,27.00769937,1.005874027,0.008449637,0.585764263,0.65216669,Upregulated
Feature0020,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,4,0,0,2,0,0,0,1.2,0.4,0.2,54.6,6,2,0,0.333333333,0,Phenol,19.84399936,19.95388234,1.00553734,0.007966657,0.623313031,0.687018371,Upregulated
Feature0499,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0499,9,9,6,0,0,2,0,3,4,1,0.666666667,0.222222222,53.96666667,8,2,1.166666667,1.333333333,-7,Other,24.42952823,24.55524443,1.005146075,0.00740518,0.270076275,0.336067763,Upregulated
Feature0062,NA,NA,360.22765,NA,Feature0062,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.39060542,22.47991626,1.003988764,0.005743124,0.773666336,0.818300933,Upregulated
Feature0235,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,7,0,0,0,0,0,0,1.333333333,1.166666667,1,31.8,3,-4,4,-0.2,-4,Other,29.50925625,29.62467368,1.003911228,0.005631703,0.669364431,0.721408082,Upregulated
Feature0500,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0500,11,18,6,0,0,3,0,1,1,1.636363636,0.545454545,0,60.3,5,-1,#NAME?,-1,-6,Protein,21.72420993,21.80620531,1.003774378,0.005435026,0.889828203,0.909675672,Upregulated
Feature0091,Phenacetin isomer 1,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin isomer 1,10,13,2,0,0,1,0,0,0,1.3,0.2,-0.6,77.4,5,3,0.285714286,0.375,2,Phenol,22.70488434,22.77872371,1.003252136,0.004684228,0.904020255,0.919059409,Upregulated
Feature0009,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,3,0,0,4,0,0,0,1.636363636,0.272727273,0,60.3,5,2,-0.5,-0.090909091,-2,Lipid,23.97321169,24.0425604,1.002892759,0.004167344,0.640626391,0.696333034,Upregulated
Feature0173,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,2,0,0,1,0,0,0,1.222222222,0.222222222,-0.444444444,72.96666667,5,3,0.333333333,0.428571429,2,Phenol,29.16803568,29.25139531,1.00285791,0.004117212,0.80319592,0.846279227,Upregulated
Feature0492,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0492,6,1,5,0,0,6,0,3,2,0.166666667,0.833333333,2.666666667,-15.7,11,6,0.5,0.333333333,-5,Other,24.27683232,24.3372408,1.002488318,0.003585425,0.509899627,0.581835674,Upregulated
Feature0357,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,9,0,0,4,0,1,0,1.16,0.36,-0.16,64.86,14,5,0,0.290322581,0,Phenol,21.59737501,21.6504089,1.002455571,0.003538298,0.864416458,0.888652434,Upregulated
Feature0124,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,3,0,0,2,0,0,0,1.384615385,0.230769231,-0.461538462,73.45384615,6,3,0.125,0.263157895,1,Phenol,20.58311349,20.62960099,1.002258526,0.003254691,0.938576756,0.950676272,Upregulated
Feature0168,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,3,0,0,1,0,0,0,1.222222222,0.333333333,-0.222222222,66.63333333,5,2,0.2,0.384615385,1,Phenol,26.35345108,26.37959011,1.000991863,0.001430247,0.988762082,0.989034531,Upregulated
Feature0250,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,0,0,0,1,0,0,0,1.125,0,-0.75,81.675,5,5,0.571428571,0.571428571,4,Unsaturated HC,26.36013241,26.37614201,1.000607342,8.76E-04,0.960950539,0.969766599,Upregulated
Feature0167,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,2,0,0,1,0,0,0,2.333333333,0.666666667,0,60.3,1,-1,#NAME?,-1,-2,Other,26.52146506,26.5352744,1.000520686,7.51E-04,0.949101712,0.959569745,Upregulated
Feature0513,NA,NA,257.89211,NA,Feature0513,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.95738836,24.93480543,0.99909514,-0.001306027,0.829830251,0.867693228,Downregulated
Feature0400,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,7,0,0,1,0,0,0,1.833333333,1.166666667,1,31.8,2,-5,3,-1.666666667,-6,Carbohydrate,28.65087755,28.62370629,0.999051643,-0.001368839,0.919010295,0.932575022,Downregulated
Feature0295,"3,4-Dihydroxyphenylpropionic acid",C9 H10 O4,164.04738,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other","3,4-Dihydroxyphenylpropionic acid-peak1",9,10,4,0,0,0,0,0,0,1.111111111,0.444444444,-0.222222222,66.63333333,5,1,0.2,0.428571429,1,Phenol,21.46427671,21.42669986,0.998249331,-0.002527895,0.868480709,0.891164907,Downregulated
Feature0284,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,3,0,0,2,0,0,0,0.857142857,0.428571429,0.857142857,35.87142857,6,3,0.5,0.714285714,1,Phenol,22.23072637,22.18611014,0.997993037,-0.002898344,0.853890277,0.882781301,Downregulated
Feature0383,[Similar to: Isoleucine],C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",[Similar to: Isoleucine]-peak1,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,23.58197188,23.52900502,0.997753926,-0.003244044,0.989034531,0.989034531,Downregulated
Feature0090,Phenacetin isomer 2,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin isomer 2,10,13,2,0,0,1,0,0,0,1.3,0.2,-0.6,77.4,5,3,0.285714286,0.375,2,Phenol,25.75936019,25.69783107,0.997611388,-0.003450161,0.851351627,0.882781301,Downregulated
Feature0166,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,0,0,1,0,0,0,2.083333333,0.083333333,-1.666666667,107.8,1,0,-0.1,-0.047619048,-1,Lipid,25.06681346,25.00597407,0.997572911,-0.003505806,0.972632846,0.977967213,Downregulated
Feature0111,NP-008521,C14 H18 N2 O2,268.1171,NA,NP-008521,14,18,2,0,0,2,0,0,0,1.285714286,0.142857143,-0.571428571,76.58571429,7,5,0.3,0.363636364,3,Phenol,20.16012609,20.10730495,0.99737992,-0.003784937,0.850035495,0.882781301,Downregulated
Feature0532,NA,C11 H22 N2 O3,230.16304,NA,Feature0532,11,22,3,0,0,2,0,0,0,2,0.272727273,-0.909090909,86.20909091,2,-1,-0.5,-0.2,-3,Lipid,24.87104899,24.80578833,0.997376039,-0.003790551,0.829697296,0.867693228,Downregulated
Feature0245,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,3,0,0,6,0,0,0,4,1,4,-53.7,1,-2,1.333333333,1.444444444,-8,Other,22.16804613,22.10341429,0.99708446,-0.004212379,0.863426656,0.888652434,Downregulated
Feature0008,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,3,0,0,2,0,0,0,2,0.272727273,-0.909090909,86.20909091,2,-1,-0.5,-0.2,-3,Lipid,23.40591767,23.33602414,0.997013852,-0.004314546,0.974991275,0.978549638,Downregulated
Feature0279,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,7,0,0,1,0,0,0,1.666666667,0.777777778,0.222222222,53.96666667,3,-4,-5,-0.333333333,-5,Carbohydrate,25.28151571,25.20061871,0.996800153,-0.004623806,0.853360588,0.882781301,Downregulated
Feature0255,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,3,0,0,5,0,0,0,1.533333333,0.2,-0.133333333,64.1,7,4,-0.142857143,0.058823529,-1,Lipid,23.38587968,23.30748777,0.996647896,-0.004844188,0.969759033,0.976863495,Downregulated
Feature0330,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,0,0,4,0,0,0,1.692307692,0.307692308,-0.153846154,64.68461538,5,1,-0.6,-0.142857143,-3,Protein,19.60142393,19.51835996,0.99576235,-0.006126627,0.857005769,0.884339912,Downregulated
Feature0164,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,5,0,0,2,0,0,0,1.818181818,0.454545455,-0.363636364,70.66363636,3,-2,-1,-0.230769231,-4,Protein,23.4993401,23.38745282,0.995238706,-0.006885501,0.898229947,0.916561171,Downregulated
Feature0153,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,0,0,0,1,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,25.68889248,25.55472731,0.994777308,-0.007554496,0.640407712,0.696333034,Downregulated
Feature0007,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,2,0,0,1,0,0,0,2.2,0.4,-0.8,83.1,1,-1,-1,-0.333333333,-2,Protein,27.55697669,27.40993771,0.994664183,-0.007718567,0.638016449,0.696333034,Downregulated
Feature0360,[Similar to: Ne-Acetyllysine],C8 H16 N2 O3,188.11612,Metabolic pathways;Other,[Similar to: Ne-Acetyllysine]-peak2,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,24.6588104,24.52672361,0.994643424,-0.007748677,0.58821576,0.653573067,Downregulated
Feature0494,NA,C11 H23 N3 O3,245.17392,NA,Feature0494,11,23,3,0,0,3,0,0,0,2.090909091,0.272727273,-0.727272727,81.02727273,2,-1,-0.8,-0.384615385,-4,Lipid,23.27928529,23.11683377,0.993021628,-0.010102955,0.468986992,0.544183219,Downregulated
Feature0010,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,3,0,0,5,0,0,0,2.090909091,0.272727273,-0.181818182,65.48181818,3,0,-1.666666667,-0.777777778,-5,Lipid,23.74867695,23.57231243,0.992573712,-0.010753849,0.574156695,0.644448233,Downregulated
Feature0116,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,2,0,0,1,0,0,0,0.833333333,0.333333333,0.333333333,50.8,5,3,0.666666667,0.75,2,Phenol,24.84482484,24.65246888,0.992257705,-0.011213235,0.075510755,0.11409592,Downregulated
Feature0526,NA,C20 H32 N6 O3,404.25385,NA,Feature0526,20,32,3,0,0,6,0,0,0,1.6,0.15,-0.4,71.7,8,5,-0.090909091,0.04,-1,Lipid,21.51841035,21.34009065,0.991713157,-0.012005199,0.661177235,0.714435126,Downregulated
Feature0351,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,0,0,0,10,0,0,0,0.666666667,0,4.333333333,-63.2,10,10,0,0,0,Condensed HC,24.65513207,24.44286082,0.991390383,-0.012474831,0.413512002,0.492276193,Downregulated
Feature0335,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,3,0,0,1,0,0,0,1.3,0.3,-0.4,71.7,5,2,0.166666667,0.333333333,1,Phenol,22.04495459,21.84973092,0.991144293,-0.012832992,0.413074615,0.492276193,Downregulated
Feature0128,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,0,0,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.142857143,-1,Phenol,23.58728604,23.3719845,0.990872136,-0.013229193,0.115707961,0.162760559,Downregulated
Feature0411,[Similar to: 6-Aminocaproic acid],C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",[Similar to: 6-Aminocaproic acid]-peak2,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,21.86364524,21.65963426,0.99066894,-0.013525074,0.437756287,0.514457175,Downregulated
Feature0191,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,2,0,0,1,0,0,0,0.9,0.2,-0.2,66,7,5,0.571428571,0.625,4,Phenol,22.44171264,22.22954564,0.990545864,-0.013704319,0.871903749,0.893011288,Downregulated
Feature0491,NA,NA,121.9172,Microbial metabolism in diverse environments;Other,Feature0491,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.36776404,24.08820787,0.988527623,-0.016646814,0.166379016,0.227632982,Downregulated
Feature0472,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,5,0,0,6,0,0,0,0.8,0.5,2,3.3,10,5,1,1,-1,Condensed HC,20.538128,20.29352531,0.988090312,-0.017285183,0.720787092,0.771270234,Downregulated
Feature0248,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,2,0,0,1,0,0,0,2.2,0.4,-0.8,83.1,1,-1,-1,-0.333333333,-2,Protein,29.85704216,29.4767905,0.987264256,-0.0184918,0.058643546,0.091891597,Downregulated
Feature0525,NA,C18 H23 N5,309.19516,NA,Feature0525,18,23,0,0,0,5,0,0,0,1.277777778,0,-0.444444444,72.96666667,10,10,0.384615385,0.384615385,5,Unsaturated HC,25.17071444,24.83895722,0.986819714,-0.019141558,0.89991187,0.916576905,Downregulated
Feature0054,NA,NA,264.07224,NA,Feature0054,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.44552184,26.08707672,0.986445905,-0.019688157,0.263325621,0.329906815,Downregulated
Feature0027,NA,NA,241.10379,NA,Feature0027,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,19.70010052,19.43037143,0.986308238,-0.019889511,0.640290424,0.696333034,Downregulated
Feature0099,NP-021733 mzCloud,C7 H13 N O2,143.09464,ABC transporters,NP-021733 mzCloud,7,13,2,0,0,1,0,0,0,1.857142857,0.285714286,-0.857142857,84.72857143,2,0,-0.25,0,-1,Lipid,21.2682025,20.9576761,0.9853995,-0.021219356,0.324333452,0.399962778,Downregulated
Feature0079,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,3,0,0,1,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.272727273,0,Phenol,24.56105913,24.18877657,0.984842569,-0.022034972,0.208525972,0.272421103,Downregulated
Feature0399,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,4,0,0,1,0,1,0,2.8,0.8,-1.6,105.9,0,-4,6,-4,-6,Other,23.38985559,23.01677703,0.984049557,-0.023197123,0.563509863,0.636143348,Downregulated
Feature0467,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,14,0,0,1,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,25.36399222,24.89327106,0.981441362,-0.027026022,0.056077333,0.08888338,Downregulated
Feature0017,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,0,0,2,0,0,0,1.2,0.4,0.8,37.5,4,2,0,0.5,0,Phenol,25.206694,24.73538916,0.981302394,-0.027230316,0.005502481,0.013101146,Downregulated
Feature0185,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,2,0,0,1,0,0,0,2.2,0.4,-0.8,83.1,1,-1,-1,-0.333333333,-2,Protein,21.78582562,21.32763349,0.978968338,-0.030665895,0.084343017,0.123374094,Downregulated
Feature0222,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,5,0,0,1,0,0,0,1.888888889,0.555555556,-0.444444444,72.96666667,2,-3,-1.333333333,-0.272727273,-4,Amino Sugar,23.75087745,23.22088013,0.977685148,-0.032558158,0.042247591,0.069155282,Downregulated
Feature0082,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,8,0,0,1,0,0,0,1.5,0.8,0.4,48.9,4,-4,-5,-0.2,-5,Carbohydrate,25.37553185,24.80477831,0.977507721,-0.032819997,0.030206876,0.053592845,Downregulated
Feature0268,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,2,0,0,1,0,0,0,2.214285714,0.142857143,-1.714285714,109.1571429,0,-2,-0.272727273,-0.166666667,-3,Lipid,25.19175974,24.54231781,0.974220065,-0.037680398,0.851119708,0.882781301,Downregulated
Feature0440,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,10,0,0,1,0,2,0,1.681818182,0.454545455,-1.090909091,91.39090909,6,-4,-0.777777778,-0.142857143,-7,Protein,22.98214768,22.38918359,0.974198926,-0.037711702,0.407339503,0.488097443,Downregulated
Feature0442,"[Similar to: 3,4-Methylenedioxy-N-propylamphetamine]",C13 H19 N O2,221.14159,NA,"[Similar to: 3,4-Methylenedioxy-N-propylamphetamine]",13,19,2,0,0,1,0,0,0,1.461538462,0.153846154,-0.923076923,86.60769231,5,3,0.2,0.272727273,2,Phenol,26.66169514,25.94012643,0.972936128,-0.039582998,0.746352341,0.795530596,Downregulated
Feature0257,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,2,0,0,3,0,0,0,1.833333333,0.333333333,0.333333333,50.8,3,1,-2,-0.5,-2,Protein,26.2343577,25.51347612,0.97252147,-0.040197994,0.652823629,0.706797236,Downregulated
Feature0393,[Similar to: D-Raffinose],C18 H32 O16,526.15108,NA,[Similar to: D-Raffinose]-peak2,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,25.29743355,24.58428955,0.971809631,-0.041254365,0.582803057,0.650185966,Downregulated
Feature0287,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,3,0,0,2,0,0,0,2,0.3,-0.8,83.1,2,-1,-0.6,-0.230769231,-3,Lipid,23.79548619,23.10867705,0.971136999,-0.042253263,0.825695258,0.86666487,Downregulated
Feature0301,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,0,0,0,1,0,0,0,2.2,0,-1.6,105.9,1,1,0,0,0,Lipid,25.95377083,25.15740471,0.969315976,-0.044961065,0.481646265,0.555748345,Downregulated
Feature0480,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,9,0,0,1,0,0,0,1.7,0.9,0.4,48.9,3,-6,#NAME?,-0.555555556,-7,Carbohydrate,26.29145741,25.40355519,0.96622849,-0.049563703,0.051065115,0.081882837,Downregulated
Feature0273,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,20.76718564,20.06406271,0.966142599,-0.049691954,0.082845445,0.121831537,Downregulated
Feature0199,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,1,0,0,5,0,0,0,1,0.2,2.4,-8.1,6,5,0,-1,0,Phenol,26.31024587,25.40417547,0.96556207,-0.05055909,0.012641777,0.026041114,Downregulated
Feature0341,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,6,0,0,0,0,1,0,2.6,1.2,-1.2,94.5,0,-6,3.5,-4,-7,Other,22.37956415,21.52906769,0.961996737,-0.055896094,0.011395358,0.024105566,Downregulated
Feature0258,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,24.02264168,23.1084013,0.961942554,-0.055977354,0.705366682,0.756241082,Downregulated
Feature0381,[Similar to: Leu-ala],C9 H18 N2 O3,202.1317,NA,[Similar to: Leu-ala]-peak3,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,24.63903589,23.67725148,0.960965014,-0.057444187,0.564432643,0.636143348,Downregulated
Feature0263,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,4,0,0,1,0,0,0,1.888888889,0.444444444,-0.666666667,79.3,2,-2,-0.75,-0.166666667,-3,Protein,22.15388786,21.2400097,0.958748633,-0.060775479,0.174915791,0.23637269,Downregulated
Feature0068,NA,NA,244.06955,Metabolic pathways;ABC transporters;Other,Feature0068,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.63988183,24.54298501,0.957219116,-0.063078887,0.64042382,0.696333034,Downregulated
Feature0475,"[Similar to: (2R,3R,4S,5S,6R)-2-[2-(4-methoxyphenyl)ethoxy]-6-({[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol; ΔMass: -117.0465 Da]",C6 H20 N9 O5 P,329.13228,NA,"[Similar to: (2R,3R,4S,5S,6R)-2-[2-(4-methoxyphenyl)ethoxy]-6-({[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol; ΔMass: -117.0465 Da]",6,20,5,0,0,9,0,1,0,3.333333333,0.833333333,2,3.3,2,-3,1.444444444,1.615384615,-13,Other,24.06708676,23.01801087,0.95641035,-0.064298353,0.019375174,0.03725995,Downregulated
Feature0188,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,0,0,0,1,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,22.7283579,21.66887155,0.953384826,-0.068869431,0.077619564,0.116323597,Downregulated
Feature0320,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,0,0,0,1,0,0,0,1.761904762,0,-1.619047619,106.4428571,4,4,0.15,0.15,3,Lipid,25.44741589,24.25263774,0.953049137,-0.069377498,0.671565342,0.721408082,Downregulated
Feature0350,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,0,0,0,10,0,0,0,0.666666667,0,4.333333333,-63.2,10,10,0,0,0,Condensed HC,24.96263991,23.77920183,0.952591629,-0.070070223,0.016623843,0.032653977,Downregulated
Feature0366,[Similar to: muramic acid],C9 H17 N O7,251.10185,Metabolic pathways;ABC transporters;Other,[Similar to: muramic acid],9,17,7,0,0,1,0,0,0,1.888888889,0.777777778,0,60.3,2,-5,-6,-0.555555556,-6,Carbohydrate,24.29651559,23.09585692,0.950583092,-0.073115354,0.150687649,0.209288401,Downregulated
Feature0077,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,0,0,2,0,0,0,1.6,0.4,0.4,48.9,3,1,-1,0,-1,Protein,25.19693486,23.93372076,0.949866359,-0.074203547,0.003399214,0.009490191,Downregulated
Feature0001,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,2,0,0,1,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,27.14176263,25.76662422,0.949334963,-0.075010877,6.03E-04,0.00325103,Downregulated
Feature0061,NA,NA,175.08448,NA,Feature0061,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.01433212,23.73824794,0.948985879,-0.075541476,0.01151497,0.024265262,Downregulated
Feature0143,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,3,0,0,1,0,0,0,1.1,0.3,-0.2,66,6,3,0.333333333,0.466666667,2,Phenol,23.47197857,22.25827032,0.948291183,-0.076597973,0.161621356,0.222003121,Downregulated
Feature0376,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17868,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak3,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,24.73195835,23.42990084,0.947353239,-0.078025633,0.011336787,0.024074258,Downregulated
Feature0083,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,2,0,0,1,0,0,0,1.8,0.4,-0.4,71.7,2,0,-0.5,0,-1,Protein,28.71867331,27.14323942,0.945142525,-0.081396194,0.033083801,0.057765367,Downregulated
Feature0187,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,28.36191011,26.71915598,0.942078861,-0.086080263,0.442834384,0.519315375,Downregulated
Feature0004,α-Lactose,C12 H22 O11,359.14285,NA,α-Lactose,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,25.71857916,24.21320434,0.941467419,-0.087016926,0.038683636,0.064865853,Downregulated
Feature0288,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,3,0,0,2,0,0,0,2,0.3,-0.8,83.1,2,-1,-0.6,-0.230769231,-3,Lipid,24.54354094,23.08068672,0.940397589,-0.088657255,0.457354701,0.534066,Downregulated
Feature0207,DL-Tryptophan isomer 2,C11 H12 N2 O2,187.06332,Microbial metabolism in diverse environments;Other,DL-Tryptophan isomer 2,11,12,2,0,0,2,0,0,0,1.090909091,0.181818182,-0.181818182,65.48181818,7,5,0.428571429,0.5,3,Phenol,27.44762863,25.80836681,0.940276742,-0.088842662,0.466356537,0.542275043,Downregulated
Feature0156,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,4,0,0,2,0,0,0,2,0.4,-0.6,77.4,2,-2,-1,-0.333333333,-4,Protein,24.89573888,23.40612012,0.940165714,-0.089013026,0.262304857,0.329378245,Downregulated
Feature0227,D-(+)-Maltose,C12 H22 O11,364.09813,NA,D-(+)-Maltose,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,28.24103745,26.53793842,0.939694176,-0.089736787,0.004928008,0.012154281,Downregulated
Feature0352,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,4,0,0,6,0,0,0,1.6,0.8,3.6,-42.3,5,1,1,1,-5,Carbohydrate,26.354028,24.74293525,0.938867305,-0.091006826,0.004342707,0.011057819,Downregulated
Feature0201,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,24.74365684,23.15809976,0.935920665,-0.095541853,0.424068284,0.500509777,Downregulated
Feature0444,[Similar to: 3-hydroxy-3-methylpentanedioic acid],C6 H10 O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Other,[Similar to: 3-hydroxy-3-methylpentanedioic acid],6,10,5,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,2,-3,-3,-0.142857143,-3,Carbohydrate,28.69019886,26.84667512,0.93574378,-0.095814542,0.182090922,0.243673984,Downregulated
Feature0538,NA,C10 H19 N O8,281.11106,NA,Feature0538,10,19,8,0,0,1,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,25.53544668,23.88440231,0.935343039,-0.096432521,0.009387997,0.020904447,Downregulated
Feature0123,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide,7,16,1,0,0,4,0,0,0,2.285714286,0.142857143,-0.285714286,68.44285714,2,1,-1.5,-1,-3,Lipid,22.46854488,20.93154619,0.931593314,-0.102227809,0.499519722,0.571176398,Downregulated
Feature0131,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,6,0,0,1,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,25.35423896,23.61403051,0.931364201,-0.102582665,0.005028401,0.012291646,Downregulated
Feature0484,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09545,Metabolic pathways;ABC transporters;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",9,17,8,0,0,1,0,0,0,1.888888889,0.888888889,0.222222222,53.96666667,2,-6,#NAME?,-0.75,-7,Carbohydrate,25.99727826,24.18103114,0.930137028,-0.104484825,0.009714483,0.021367088,Downregulated
Feature0421,[Similar to: 4-Penten-1-amine],C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",[Similar to: 4-Penten-1-amine]-peak2,5,11,0,0,0,1,0,0,0,2.2,0,-1.6,105.9,1,1,0,0,0,Lipid,25.20583103,23.40740203,0.928650279,-0.106792701,0.47783061,0.553277549,Downregulated
Feature0278,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,4,0,0,1,0,0,2,2.3,0.4,-0.8,83.1,0,-4,-2.333333333,-1,-7,Protein,24.29426348,22.55259768,0.928309586,-0.107322079,8.89E-04,0.004303837,Downregulated
Feature0256,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,2,0,0,1,0,0,0,1.444444444,0.222222222,-0.666666667,79.3,4,2,0.166666667,0.285714286,1,Phenol,23.18757434,21.50032634,0.927234821,-0.108993349,0.020695826,0.039386519,Downregulated
Feature0523,NA,C9 H9 N O4,179.07955,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0523,9,9,4,0,0,1,0,0,0,1,0.444444444,0.222222222,53.96666667,6,2,0.25,0.5,1,Phenol,25.76047124,23.8799752,0.927000713,-0.109357647,4.12E-04,0.002508956,Downregulated
Feature0316,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,11,0,0,0,0,1,0,2.111111111,1.222222222,-0.222222222,66.63333333,1,-10,3.666666667,-2.2,-11,Carbohydrate,23.32001532,21.61011869,0.926676865,-0.10986174,0.036948945,0.062916159,Downregulated
Feature0151,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,3,0,0,1,0,0,1,2.2,0.6,0,60.3,1,-2,#NAME?,-1.666666667,-4,Amino Sugar,26.52723508,24.57269678,0.926319562,-0.110418114,0.002801241,0.008328015,Downregulated
Feature0072,NA,NA,277.11616,NA,Feature0072,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,28.14886886,26.0206471,0.924394057,-0.11342011,0.016308449,0.032264918,Downregulated
Feature0324,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,4,0,0,3,0,0,0,1.9,0.4,-0.2,66,3,-1,-1.333333333,-0.4,-4,Protein,24.84315981,22.95807642,0.924120627,-0.113846914,1.64E-04,0.001389991,Downregulated
Feature0130,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,7,0,0,1,0,0,0,1.875,0.875,0.25,53.175,2,-5,#NAME?,-0.714285714,-6,Carbohydrate,25.92853603,23.94413694,0.923466597,-0.114868317,0.00509903,0.012409145,Downregulated
Feature0223,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,4,0,0,2,0,0,0,2,0.444444444,-0.444444444,72.96666667,2,-2,-1.333333333,-0.4,-4,Protein,25.4094602,23.46312804,0.923401279,-0.114970365,0.269145934,0.335669532,Downregulated
Feature0306,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,5,0,0,1,0,0,0,1.1,0.5,0.2,54.6,6,1,0,0.384615385,0,Phenol,20.4759016,18.90083253,0.923076937,-0.115477195,2.86E-04,0.002018804,Downregulated
Feature0228,D-(+)-Glucose isomer,C6 H12 O6,197.08998,NA,D-(+)-Glucose isomer,6,12,6,0,0,0,0,0,0,2,1,0,60.3,1,-5,#NAME?,-0.666666667,-5,Carbohydrate,26.04144438,24.03734317,0.923041857,-0.115532024,0.058500253,0.091891597,Downregulated
Feature0186,Kanosamine,C6 H13 N O5,161.06907,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Kanosamine,6,13,5,0,0,1,0,0,0,2.166666667,0.833333333,0,60.3,1,-4,#NAME?,-1,-5,Carbohydrate,24.98630715,23.04644645,0.922363049,-0.116593377,1.09E-04,0.00108325,Downregulated
Feature0359,[Similar to: Ne-Acetyllysine],C8 H16 N2 O3,188.11612,Metabolic pathways;Other,[Similar to: Ne-Acetyllysine]-peak1,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,21.19514223,19.54545096,0.922166539,-0.116900776,0.010472474,0.02261212,Downregulated
Feature0384,[Similar to: Isoleucine],C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",[Similar to: Isoleucine]-peak2,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,27.29834555,25.16363969,0.921800907,-0.117472908,0.401337826,0.483010513,Downregulated
Feature0229,D-(+)-Glucose,C6 H12 O6,197.08999,NA,D-(+)-Glucose,6,12,6,0,0,0,0,0,0,2,1,0,60.3,1,-5,#NAME?,-0.666666667,-5,Carbohydrate,30.30022017,27.85319766,0.919240768,-0.121485312,4.13E-04,0.002508956,Downregulated
Feature0179,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13722,NA,L-gamma-Glutamyl-L-leucine,11,20,5,0,0,2,0,0,0,1.818181818,0.454545455,-0.363636364,70.66363636,3,-2,-1,-0.230769231,-4,Protein,24.41120052,22.40435236,0.917789862,-0.123764224,0.490496843,0.563200968,Downregulated
Feature0224,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,9,0,0,0,0,1,0,2.166666667,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,26.04418499,23.89989235,0.917667124,-0.123957171,0.011115298,0.023880524,Downregulated
Feature0363,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,9,0,0,5,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.230769231,-6,Phenol,23.57567123,21.59434776,0.91595898,-0.126645105,0.004974418,0.012213973,Downregulated
Feature0018,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,2,0,0,0,0,0,0,1,0.5,0,60.3,3,1,0.5,0.666666667,1,Phenol,26.88214613,24.59014097,0.914738758,-0.128568314,3.42E-04,0.002268145,Downregulated
Feature0441,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,12,0,0,1,0,0,0,2.083333333,1,0.166666667,55.55,1,-11,12,-1.2,-12,Carbohydrate,25.55742398,23.359116,0.913985542,-0.129756751,0.004426919,0.011185979,Downregulated
Feature0482,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,4,0,0,6,0,0,0,1.5,1,5,-82.2,5,1,0.833333333,0.75,-5,Carbohydrate,29.23838376,26.70167623,0.913240501,-0.130933252,0.002350951,0.007498306,Downregulated
Feature0344,[Similar to: Scutellarioside II; ΔMass: -306.1127 Da],NA,202.04538,NA,[Similar to: Scutellarioside II; ΔMass: -306.1127 Da]-peak2,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,29.12800479,26.40306933,0.906449636,-0.141701232,0.005396351,0.012904318,Downregulated
Feature0321,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,6,0,0,1,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,25.02294796,22.67937016,0.906342858,-0.141871189,0.001085975,0.004762351,Downregulated
Feature0141,MFCD00025555 ChemSpider,C9 H18 N2 O3,202.1317,NA,MFCD00025555 ChemSpider,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,26.0725237,23.5390371,0.902829253,-0.14747493,0.173107746,0.234505567,Downregulated
Feature0379,[Similar to: Leu-ala],C9 H18 N2 O3,202.1317,NA,[Similar to: Leu-ala]-peak1,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,24.85275685,22.30127645,0.897336122,-0.156279607,0.224273231,0.288876527,Downregulated
Feature0483,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,7,0,0,1,0,0,0,1.4,0.466666667,-0.266666667,67.9,6,-1,-0.285714286,0.142857143,-2,Phenol,25.97261496,23.29686476,0.896978021,-0.156855461,0.022451628,0.042001345,Downregulated
Feature0086,Pipecolic acid isomer,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid isomer,6,11,2,0,0,1,0,0,0,1.833333333,0.333333333,-0.666666667,79.3,2,0,-0.333333333,0,-1,Protein,26.67070555,23.91978405,0.896856066,-0.157051626,0.003783442,0.010052624,Downregulated
Feature0305,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,5,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,2,-3,-3,-0.142857143,-3,Carbohydrate,29.0913947,26.04452081,0.895265458,-0.159612571,3.20E-04,0.002176031,Downregulated
Feature0226,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,7,0,0,0,0,0,0,2,1.166666667,0.333333333,50.8,1,-6,6,-1,-6,Carbohydrate,25.63592538,22.90303504,0.893396072,-0.162628183,0.004918998,0.012154281,Downregulated
Feature0364,[Similar to: N-Methyl-Nâ€²-piperazinoacetohydrazide],C7 H16 N4 O,172.13244,NA,[Similar to: N-Methyl-Nâ€²-piperazinoacetohydrazide],7,16,1,0,0,4,0,0,0,2.285714286,0.142857143,-0.285714286,68.44285714,2,1,-1.5,-1,-3,Lipid,22.5675491,20.16033021,0.893332728,-0.162730477,0.2125712,0.275740944,Downregulated
Feature0025,NA,NA,245.17401,NA,Feature0025,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.23330321,18.95084226,0.892505611,-0.164066856,0.00325857,0.009206307,Downregulated
Feature0158,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,0,0,3,0,0,0,2.083333333,0.25,-0.833333333,84.05,2,-1,-0.666666667,-0.333333333,-4,Lipid,25.07777555,22.28587661,0.888670391,-0.170279674,0.181881774,0.243673984,Downregulated
Feature0529,NA,C18 H25 N5 O10,471.15896,NA,Feature0529,18,25,10,0,0,5,0,0,0,1.388888889,0.555555556,0.555555556,44.46666667,9,-1,-2,-0.125,-6,Phenol,26.41449545,23.46350567,0.888281426,-0.170911271,2.13E-04,0.001649679,Downregulated
Feature0089,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,3,0,0,0,0,0,0,1,0.5,0,60.3,4,1,0.333333333,0.555555556,1,Phenol,26.29278965,23.32275975,0.887040137,-0.172928709,0.001438658,0.005494876,Downregulated
Feature0003,α-Lactose isomer,C12 H22 O11,359.14284,NA,α-Lactose isomer,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,30.89194033,27.39340642,0.886749299,-0.173401811,0.017969077,0.034922234,Downregulated
Feature0225,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,6,0,0,0,0,0,0,1.666666667,1,0.333333333,50.8,2,-4,#NAME?,-0.333333333,-4,Carbohydrate,25.32089925,22.44056577,0.886246794,-0.174219592,3.31E-04,0.00221736,Downregulated
Feature0109,NP-013538 mzCloud,C12 H16 O8,288.08457,NA,NP-013538 mzCloud-peak2,12,16,8,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,5,-3,-0.75,0.125,-3,Other,24.32905132,21.53415971,0.885121225,-0.176053037,0.001401952,0.005494876,Downregulated
Feature0203,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,4,0,0,0,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,25.36522659,22.34842299,0.881065379,-0.182679017,1.83E-04,0.001476419,Downregulated
Feature0527,NA,C18 H11 F3 N2,312.08214,NA,Feature0527,18,11,0,0,3,2,0,0,0,0.611111111,0,-0.277777778,68.21666667,14.5,14.5,0.78125,0.78125,12.5,Condensed HC,23.43257859,20.56869584,0.877782006,-0.188065398,0.022188636,0.041793664,Downregulated
Feature0121,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,0,0,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,23.04554518,20.22498073,0.877609125,-0.188349569,0.002894211,0.00855815,Downregulated
Feature0231,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,11,0,0,4,0,2,0,1.857142857,0.785714286,-0.142857143,64.37142857,5,-6,4,-2.6,-12,Carbohydrate,23.83447615,20.87918707,0.876007802,-0.190984375,1.10E-04,0.00108325,Downregulated
Feature0063,NA,NA,145.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",Feature0063,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.90942492,20.02869727,0.874255785,-0.193872657,0.013095854,0.02677591,Downregulated
Feature0136,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,7,0,0,1,0,0,0,1.888888889,0.777777778,0,60.3,2,-5,-6,-0.555555556,-6,Carbohydrate,27.65606532,24.16399416,0.873732177,-0.194736973,0.002431544,0.007526464,Downregulated
Feature0049,NA,NA,167.05586,NA,Feature0049,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.77774204,19.88282393,0.872905835,-0.196102064,0.01125079,0.023984242,Downregulated
Feature0353,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,7,0,0,1,0,0,0,2.5,1.166666667,0.333333333,50.8,0,-7,4,-3,-8,Carbohydrate,25.31220277,21.92888462,0.866336479,-0.207000629,0.026556527,0.048525216,Downregulated
Feature0078,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,3,0,0,0,0,0,0,1,0.5,0,60.3,4,1,0.333333333,0.555555556,1,Phenol,26.37518257,22.82594735,0.865432771,-0.208506342,0.001480574,0.005615971,Downregulated
Feature0308,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,3,0,0,2,0,0,0,1.142857143,0.214285714,-0.285714286,68.44285714,8,5,0.333333333,0.428571429,3,Phenol,24.56589144,21.25585684,0.865258926,-0.208796176,0.036011387,0.061894571,Downregulated
Feature0276,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,4,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,3,-1,-0.5,0.25,-1,Other,26.59966017,22.99633041,0.864534745,-0.21000415,1.08E-04,0.00108325,Downregulated
Feature0307,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,3,0,0,2,0,0,0,1.333333333,0.25,-0.333333333,69.8,6,3,0.142857143,0.294117647,1,Phenol,25.7801072,22.28375303,0.864377827,-0.210266031,0.150459152,0.209288401,Downregulated
Feature0253,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,3,0,0,2,0,0,0,2,0.75,1,31.8,2,-1,3,-3,-3,Carbohydrate,26.01989145,22.48280662,0.864062276,-0.210792799,0.001026659,0.004762351,Downregulated
Feature0432,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,17,0,0,5,0,0,0,1.64,0.68,0.32,51.18,8,-9,-4.666666667,-0.47826087,-14,Amino Sugar,25.09254145,21.66436526,0.863378678,-0.211934631,6.52E-04,0.003414454,Downregulated
Feature0412,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,6,0,0,10,0,0,0,1.272727273,0.545454545,2.545454545,-12.24545455,10,4,1.2,1.5,-6,Phenol,25.96216305,22.39157202,0.862469432,-0.21345477,0.001698271,0.005983398,Downregulated
Feature0126,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,2,0,0,3,0,0,0,1.727272727,0.181818182,-0.545454545,75.84545455,4,2,-0.166666667,0,-1,Lipid,26.20010655,22.55013957,0.86068885,-0.216436316,0.002428429,0.007526464,Downregulated
Feature0232,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,5,0,0,3,0,0,0,1.444444444,0.555555556,0.666666667,41.3,5,0,-3,-0.142857143,-3,Phenol,26.35630881,22.66197925,0.8598313,-0.217874467,0.00404429,0.010592187,Downregulated
Feature0395,[Similar to: D-(+)-Maltose],C12 H22 O11,364.09814,NA,[Similar to: D-(+)-Maltose]-peak1,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,27.01054502,23.15950905,0.857424722,-0.221918081,2.66E-05,4.57E-04,Downregulated
Feature0274,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,10,0,0,1,0,0,0,1.916666667,0.833333333,0,60.3,2,-8,-9,-0.666666667,-9,Carbohydrate,27.07675516,23.2079657,0.857117685,-0.22243479,0.001980127,0.006681409,Downregulated
Feature0135,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,6,0,0,1,0,0,0,1.666666667,0.666666667,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,27.39594958,23.47779465,0.856980503,-0.222665712,0.001615356,0.005922971,Downregulated
Feature0524,NA,C10 H7 Cl N4,218.04022,NA,Feature0524,11,7,0,0,0,4,1,0,0,0.636363636,0,0.454545455,47.34545455,10.5,10.5,0.928571429,0.928571429,6.5,Condensed HC,25.57484395,21.85628593,0.85460095,-0.226677174,4.15E-04,0.002508956,Downregulated
Feature0408,"[Similar to: 7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione]",C11 H14 N4 O2,234.11165,NA,"[Similar to: 7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione]-peak1",11,14,2,0,0,4,0,0,0,1.272727273,0.181818182,0.181818182,55.11818182,7,5,0.2,0.333333333,1,Phenol,24.2909818,20.75801744,0.854556543,-0.226752141,0.183573973,0.245062343,Downregulated
Feature0286,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,1,0,0,3,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,26.2622199,22.42325668,0.853821831,-0.227993044,0.003174277,0.009150277,Downregulated
Feature0418,"[Similar to: 5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one]",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"[Similar to: 5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one]-peak2",6,8,4,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,3,-1,-0.5,0.25,-1,Other,27.1928492,23.19107155,0.852837133,-0.22965784,0.003552159,0.009768437,Downregulated
Feature0507,NA,C10 H17 N7 O8,363.11421,NA,Feature0507,10,17,8,0,0,7,0,0,0,1.7,0.8,2,3.3,6,-2,1.8,5,-9,Carbohydrate,25.90390614,22.05326673,0.851349083,-0.232177286,2.20E-05,4.09E-04,Downregulated
Feature0081,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,0,0,5,0,0,0,1.307692308,0.384615385,0.615384615,42.76153846,8,3,-0.666666667,0.090909091,-2,Phenol,26.17178921,22.19524908,0.848060058,-0.237761657,3.05E-05,4.79E-04,Downregulated
Feature0417,"[Similar to: 5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one]",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,"[Similar to: 5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one]-peak1",6,8,4,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,3,-1,-0.5,0.25,-1,Other,27.20840719,23.06105262,0.847570843,-0.238594136,6.21E-05,6.97E-04,Downregulated
Feature0160,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,6,0,0,1,0,0,0,1.7,0.6,-0.2,66,3,-3,-1.333333333,-0.166666667,-4,Amino Sugar,25.99417895,21.96550847,0.845016437,-0.242948691,0.001234447,0.005104854,Downregulated
Feature0349,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,15,0,0,0,0,2,0,1.466666667,0.5,-0.8,83.1,10,-5,-0.538461538,0.024390244,-7,Phenol,26.81795534,22.60911513,0.84305887,-0.246294718,0.00965335,0.02132266,Downregulated
Feature0012,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,3,0,0,1,0,0,0,2.75,0.75,-0.5,74.55,0,-3,#NAME?,-1.666666667,-4,Other,25.99844768,21.88798185,0.841895721,-0.248286546,0.026940422,0.04904822,Downregulated
Feature0220,D-Raffinose isomer 1,C18 H32 O16,521.19564,NA,D-Raffinose isomer 1,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,28.92935923,24.34077946,0.841386747,-0.249159001,9.25E-04,0.004386356,Downregulated
Feature0246,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,10,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,3,-7,-3.5,-0.285714286,-7,Carbohydrate,27.23181801,22.91212316,0.841373248,-0.249182148,5.88E-05,6.89E-04,Downregulated
Feature0367,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,12,0,0,1,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,27.43449882,23.02295599,0.839197251,-0.252918143,0.004433715,0.011185979,Downregulated
Feature0365,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,9,0,0,5,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.230769231,-6,Phenol,26.97901306,22.62560788,0.838637345,-0.25388102,0.007454671,0.016876536,Downregulated
Feature0409,"[Similar to: 7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione]",C11 H14 N4 O2,234.11166,NA,"[Similar to: 7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione]-peak2",11,14,2,0,0,4,0,0,0,1.272727273,0.181818182,0.181818182,55.11818182,7,5,0.2,0.333333333,1,Phenol,25.15305715,20.99864489,0.834834699,-0.26043753,0.177206838,0.238297704,Downregulated
Feature0249,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,15,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,4,-11,-3.666666667,-0.333333333,-11,Carbohydrate,26.92199147,22.40857698,0.832352131,-0.264734097,6.60E-05,7.11E-04,Downregulated
Feature0147,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,7,0,0,1,0,0,0,1.909090909,0.636363636,-0.363636364,70.66363636,2,-5,-2,-0.384615385,-6,Amino Sugar,26.65152584,22.15304121,0.831210991,-0.266713363,0.00459938,0.011550953,Downregulated
Feature0368,[Similar to: Muramic acid; ΔMass: 144.0422 Da],C16 H21 N5 O7,395.14274,NA,[Similar to: Muramic acid; ΔMass: 144.0422 Da],16,21,7,0,0,5,0,0,0,1.3125,0.4375,0.5,46.05,9,2,-0.75,0.066666667,-3,Phenol,27.25320991,22.61334584,0.829749814,-0.269251695,0.003120573,0.009125481,Downregulated
Feature0445,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,12,0,0,1,0,0,0,1.476190476,0.571428571,-0.19047619,65.72857143,7,-5,-0.75,0,-6,Phenol,28.00582709,23.18995903,0.828040499,-0.272226765,0.001708278,0.005983398,Downregulated
Feature0217,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,2,0,0,0,0,0,0,1,0.333333333,-0.333333333,69.8,4,2,0.5,0.6,2,Phenol,25.22657088,20.87632073,0.827552854,-0.273076638,0.014959821,0.03036126,Downregulated
Feature0219,D-Raffinose isomer 2,C18 H32 O16,521.19563,NA,D-Raffinose isomer 2,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,28.25991541,23.36700654,0.826860456,-0.27428422,4.44E-06,1.28E-04,Downregulated
Feature0076,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,2,0,0,0,0,0,0,0.8,0.4,0,60.3,4,2,0.666666667,0.75,2,Condensed HC,26.56233067,21.93022924,0.825613893,-0.276460847,0.012322031,0.025670898,Downregulated
Feature0342,[Similar to: Tetrolic Acid]?,C4 H4 O2,84.02115,Metabolic pathways;Other,[Similar to: Tetrolic Acid]?,4,4,2,0,0,0,0,0,0,1,0.5,0,60.3,3,1,0.5,0.666666667,1,Phenol,26.39742338,21.75949033,0.82430357,-0.278752352,0.001059659,0.004762351,Downregulated
Feature0328,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,7,0,0,1,0,0,0,1.916666667,0.583333333,-0.5,74.55,2,-5,-1.5,-0.333333333,-6,Amino Sugar,28.29504016,23.23381183,0.82112666,-0.284323317,0.001408068,0.005494876,Downregulated
Feature0386,[Similar to: Hypoxanthine],C5 H4 N4 O,136.03851,Metabolic pathways;Other,[Similar to: Hypoxanthine],5,4,1,0,0,4,0,0,0,0.8,0.2,2,3.3,6,5,Inf,3,1,Condensed HC,28.08085401,23.0067327,0.81930317,-0.287530698,3.68E-05,5.62E-04,Downregulated
Feature0117,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,1,0,0,2,0,0,0,1,0.166666667,0.333333333,50.8,5,4,0.666666667,0.714285714,2,Phenol,25.5808449,20.90324885,0.817144584,-0.291336727,8.12E-04,0.004025838,Downregulated
Feature0075,Pyrone isomer,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone isomer,5,4,2,0,0,0,0,0,0,0.8,0.4,0,60.3,4,2,0.666666667,0.75,2,Condensed HC,26.83441333,21.9088757,0.816446979,-0.292568897,2.80E-04,0.002002706,Downregulated
Feature0172,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,3,0,0,1,0,0,0,1.4,0.6,0.4,48.9,3,0,-1,0.2,-1,Phenol,28.29659795,23.08526857,0.815831946,-0.293656095,9.00E-04,0.004303837,Downregulated
Feature0517,NA,C11 H21 N O8 S,327.09887,Other,Feature0517,11,21,8,0,0,1,0,0,1,1.909090909,0.727272727,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,25.47923135,20.70049399,0.81244578,-0.299656559,0.001356305,0.005485058,Downregulated
Feature0190,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,5,0,0,4,0,0,0,1.2,0.5,1,31.8,7,2,-2,0.142857143,-2,Phenol,27.27202444,22.14670457,0.812066761,-0.300329756,3.13E-04,0.002176031,Downregulated
Feature0392,[Similar to: D-Raffinose],C18 H32 O16,526.15105,NA,[Similar to: D-Raffinose]-peak1,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,27.79701659,22.56929405,0.811932244,-0.300568756,0.027110289,0.04904822,Downregulated
Feature0419,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,4,0,0,8,0,1,0,1.833333333,0.666666667,2.666666667,-15.7,6,2,1,1,-7,Amino Sugar,27.27609549,22.13365221,0.81146703,-0.301395615,0.001023765,0.004762351,Downregulated
Feature0013,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,2,0,0,1,0,0,0,1,0.285714286,0,60.3,5,3,0.5,0.6,2,Phenol,25.88026855,20.92113637,0.808381734,-0.306891371,0.005621392,0.01326938,Downregulated
Feature0512,NA,C18 H34 N2 O12,470.2113,NA,Feature0512,18,34,12,0,0,2,0,0,0,1.888888889,0.666666667,-0.222222222,66.63333333,3,-9,-2.75,-0.5,-11,Amino Sugar,26.76320957,21.62501103,0.808012618,-0.307550272,9.77E-06,2.27E-04,Downregulated
Feature0413,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,5,0,0,6,0,0,0,1.75,0.625,1.75,10.425,5,0,2,7,-6,Amino Sugar,25.77181386,20.74108255,0.804797158,-0.313302885,1.53E-06,7.01E-05,Downregulated
Feature0354,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,17,0,0,5,0,0,0,1.64,0.68,0.32,51.18,8,-9,-4.666666667,-0.47826087,-14,Amino Sugar,27.11876187,21.813249,0.804360063,-0.314086643,0.004095531,0.010675555,Downregulated
Feature0333,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,7,0,0,1,0,0,0,1.9,0.7,-0.2,66,2,-5,-3,-0.454545455,-6,Amino Sugar,28.19800378,22.67343561,0.804079458,-0.314590021,0.011734585,0.02463367,Downregulated
Feature0098,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,3,0,0,1,0,0,0,2.166666667,0.5,-0.666666667,79.3,1,-2,-1.5,-0.428571429,-3,Protein,26.00500552,20.79182711,0.799531732,-0.322772802,6.08E-05,6.97E-04,Downregulated
Feature0531,NA,C16 H29 N O13,443.16395,NA,Feature0531,16,29,13,0,0,1,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.529411765,-11,Carbohydrate,27.60375477,22.00975024,0.797346246,-0.326721748,7.60E-04,0.003868922,Downregulated
Feature0446,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,8,0,0,5,0,0,0,1.526315789,0.421052632,0.105263158,57.3,8,0,-0.833333333,-0.1,-5,Protein,28.62397047,22.80606,0.796746909,-0.327806578,1.49E-04,0.001282948,Downregulated
Feature0528,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0528,14,26,10,0,0,6,0,0,0,1.857142857,0.714285714,0.857142857,35.87142857,5,-5,5.5,-2,-11,Carbohydrate,23.49446094,18.67598115,0.794909966,-0.331136629,3.91E-04,0.002501763,Downregulated
Feature0434,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,14,0,0,1,0,2,0,1.678571429,0.5,-0.928571429,86.76428571,7,-7,-0.909090909,-0.166666667,-10,Protein,27.14781725,21.57208163,0.794615693,-0.331670809,0.001706064,0.005983398,Downregulated
Feature0145,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate,12,21,9,0,0,1,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.384615385,-7,Carbohydrate,26.77922231,21.27633455,0.794509053,-0.331864437,0.073488827,0.111654295,Downregulated
Feature0102,NP-019811 mzCloud,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811 mzCloud,6,7,2,0,0,1,0,0,0,1.166666667,0.333333333,0,60.3,4,2,0.333333333,0.5,1,Phenol,27.75069455,22.00192464,0.792842305,-0.33489415,0.016880714,0.033040544,Downregulated
Feature0267,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,2,0,0,4,0,0,0,1.272727273,0.181818182,0.181818182,55.11818182,7,5,0.2,0.333333333,1,Phenol,25.6764939,20.30821061,0.790926156,-0.33838509,0.036760124,0.062789031,Downregulated
Feature0481,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,11,0,0,1,0,0,0,1.642857143,0.785714286,0.142857143,56.22857143,4,-7,-4,-0.333333333,-8,Carbohydrate,27.36901362,21.58897732,0.788810939,-0.342248537,0.001709845,0.005983398,Downregulated
Feature0348,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,18,0,0,4,0,0,0,1.6,0.72,0.32,51.18,8,-10,-4.666666667,-0.416666667,-14,Carbohydrate,28.11196264,22.17111477,0.788671892,-0.342502868,0.002360912,0.007498306,Downregulated
Feature0262,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,0,0,0,5,0,0,0,1,0,2,3.3,6,6,Inf,Inf,1,Unsaturated HC,28.11493934,22.15463641,0.788002284,-0.343728284,2.20E-04,0.001682936,Downregulated
Feature0394,[Similar to: D-Raffinose],C18 H32 O16,526.15103,NA,[Similar to: D-Raffinose]-peak3,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,26.35438229,20.70871588,0.785778837,-0.347804781,0.001043874,0.004762351,Downregulated
Feature0468,"[Similar to: (3R)-4,4-Dimethyl-2-oxotetrahydro-3-furanyl beta-D-glucopyranoside; ΔMass: 49.0164 Da]",C13 H19 N5 O6,341.13224,Metabolic pathways;Other,"[Similar to: (3R)-4,4-Dimethyl-2-oxotetrahydro-3-furanyl beta-D-glucopyranoside; ΔMass: 49.0164 Da]",13,19,6,0,0,5,0,0,0,1.461538462,0.461538462,0.615384615,42.76153846,7,1,-2,-0.2,-4,Phenol,29.48765916,23.12225822,0.784133393,-0.350828996,0.001400142,0.005494876,Downregulated
Feature0326,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,9,0,0,2,0,1,0,1.444444444,1,0.666666667,41.3,5,-4,2.333333333,-1.666666667,-7,Other,27.7883259,21.74603705,0.78256017,-0.353726411,0.005599771,0.01326938,Downregulated
Feature0247,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,10,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,3,-7,-3.5,-0.285714286,-7,Carbohydrate,29.4442174,22.98759257,0.780716711,-0.357128944,0.001891484,0.00646159,Downregulated
Feature0396,[Similar to: D-(+)-Maltose],C12 H22 O11,364.09813,NA,[Similar to: D-(+)-Maltose]-peak2,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,27.50136194,21.44772109,0.779878507,-0.358678703,0.008351384,0.018671795,Downregulated
Feature0338,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,13,0,0,1,0,0,0,1.823529412,0.764705882,-0.117647059,63.65294118,3,-10,-3.666666667,-0.473684211,-11,Carbohydrate,28.10673129,21.80401589,0.775757795,-0.366321807,0.003701079,0.009929724,Downregulated
Feature0157,Maltotetraose,C24 H42 O21,688.20401,NA,Maltotetraose,24,42,21,0,0,0,0,0,0,1.75,0.875,0,60.3,4,-17,-5.666666667,-0.481481481,-17,Carbohydrate,27.45316967,21.26392808,0.774552751,-0.368564598,0.003264054,0.009206307,Downregulated
Feature0431,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,17,0,0,5,0,0,0,1.64,0.68,0.32,51.18,8,-9,-4.666666667,-0.47826087,-14,Amino Sugar,26.9174727,20.74601427,0.770726677,-0.375708768,0.000616619,0.003292628,Downregulated
Feature0221,D-Raffinose,C18 H32 O16,526.15103,NA,D-Raffinose,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,27.74669598,21.36710439,0.770077432,-0.376924577,0.025274656,0.046336869,Downregulated
Feature0345,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,2,0,0,5,0,0,0,1.727272727,0.181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,27.01646029,20.78902841,0.7694949,-0.37801633,4.40E-05,6.05E-04,Downregulated
Feature0048,NA,NA,454.10871,NA,Feature0048,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,27.00720713,20.73011358,0.767577094,-0.381616435,0.01194978,0.024990035,Downregulated
Feature0069,NA,NA,310.06652,NA,Feature0069,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,27.80619459,21.17100558,0.761377308,-0.393316523,4.11E-08,1.13E-05,Downregulated
Feature0397,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,6,0,0,1,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,23.95753944,18.17510263,0.758638118,-0.398516233,0.00389287,0.010293646,Downregulated
Feature0355,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,14,0,0,1,0,2,0,1.678571429,0.5,-0.928571429,86.76428571,7,-7,-0.909090909,-0.166666667,-10,Protein,27.97799075,21.2207635,0.758480611,-0.398815794,1.76E-06,7.46E-05,Downregulated
Feature0447,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,7,0,0,1,0,0,0,2.090909091,0.636363636,-0.545454545,75.84545455,1,-6,-2.333333333,-0.538461538,-7,Amino Sugar,26.99756157,20.46422375,0.75800267,-0.399725165,0.001705121,0.005983398,Downregulated
Feature0285,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,2,0,0,3,0,0,0,2.2,0.4,0.4,48.9,2,0,#NAME?,-2,-3,Protein,26.08547136,19.66154819,0.753735592,-0.407869576,0.001438355,0.005494876,Downregulated
Feature0108,NP-013538 mzCloud,C12 H16 O8,310.06652,NA,NP-013538 mzCloud-peak1,12,16,8,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,5,-3,-0.75,0.125,-3,Other,28.20356623,21.23435819,0.752896212,-0.409477094,2.36E-04,0.001778379,Downregulated
Feature0299,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,11,0,0,1,0,0,0,1.928571429,0.785714286,-0.142857143,64.37142857,2,-9,-5,-0.6,-10,Carbohydrate,27.60503395,20.70035991,0.749876271,-0.415275524,0.007330585,0.016799258,Downregulated
Feature0369,[Similar to: methyl N-acetylneuraminate],C12 H21 N O9,323.12167,NA,[Similar to: methyl N-acetylneuraminate]-peak1,12,21,9,0,0,1,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.384615385,-7,Carbohydrate,27.52249735,20.59707119,0.748372174,-0.418172177,0.00363002,0.009819346,Downregulated
Feature0370,[Similar to: methyl N-acetylneuraminate],C12 H21 N O9,323.12167,NA,[Similar to: methyl N-acetylneuraminate]-peak2,12,21,9,0,0,1,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.384615385,-7,Carbohydrate,28.91349563,21.53195637,0.744702634,-0.425263634,5.58E-04,0.003068036,Downregulated
Feature0120,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,3,0,0,2,0,0,0,2,0.428571429,-0.285714286,68.44285714,2,-1,-1.5,-0.428571429,-3,Protein,28.96219984,21.55960841,0.74440507,-0.425840213,4.51E-05,6.05E-04,Downregulated
Feature0469,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,18,0,0,5,0,0,0,1.72,0.72,0.32,51.18,7,-11,-8,-0.636363636,-16,Carbohydrate,28.00460438,20.82456295,0.74361211,-0.42737783,0.006119762,0.014083134,Downregulated
Feature0104,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,4,0,0,2,0,0,0,1.636363636,0.363636364,-0.363636364,70.66363636,4,0,-0.4,0,-2,Protein,28.43456831,21.13352836,0.743233663,-0.428112249,0.001729746,0.005983398,Downregulated
Feature0056,NA,NA,283.10322,NA,Feature0056,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.60710358,19.72972345,0.741520902,-0.431440734,0.0013336,0.005473733,Downregulated
Feature0415,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,5,0,0,6,0,0,0,1.75,0.625,1.75,10.425,5,0,2,7,-6,Amino Sugar,26.65722635,19.757836,0.741181237,-0.432101735,3.18E-04,0.002176031,Downregulated
Feature0506,NA,C22 H39 N O17,589.22211,NA,Feature0506,22,39,17,0,0,1,0,0,0,1.772727273,0.772727273,-0.090909091,62.89090909,4,-13,-3.5,-0.44,-14,Carbohydrate,27.70092003,20.5018306,0.740113707,-0.43418116,1.13E-04,0.001090929,Downregulated
Feature0470,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,16,0,0,6,0,0,0,1.363636364,0.727272727,0.909090909,34.39090909,11,-5,#NAME?,-0.375,-11,Other,29.19217519,21.53428026,0.737673028,-0.438946609,4.68E-07,3.61E-05,Downregulated
Feature0071,NA,NA,230.07661,NA,Feature0071,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.48567962,18.66638536,0.732426431,-0.449244241,0.003039658,0.008940171,Downregulated
Feature0430,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,13,0,0,1,0,0,1,1.823529412,0.764705882,0,60.3,3,-10,-6,-0.647058824,-12,Carbohydrate,27.47332572,20.07857118,0.730838756,-0.452374954,8.91E-08,1.63E-05,Downregulated
Feature0471,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,16,0,0,6,0,0,0,1.363636364,0.727272727,0.909090909,34.39090909,11,-5,#NAME?,-0.375,-11,Other,29.49467896,21.52321036,0.729731976,-0.454561423,2.28E-07,2.94E-05,Downregulated
Feature0340,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,5,0,0,6,0,0,0,1.428571429,0.714285714,2.571428571,-12.98571429,6,1,1.25,1.666666667,-5,Other,29.39408894,21.43107705,0.729094788,-0.455821706,0.004652717,0.011588785,Downregulated
Feature0030,NA,NA,281.08757,NA,Feature0030,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.80515074,19.50300756,0.727584327,-0.458813629,0.003965518,0.010435573,Downregulated
Feature0416,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,5,0,0,6,0,0,0,1.75,0.625,1.75,10.425,5,0,2,7,-6,Amino Sugar,26.73720919,19.37365055,0.724595092,-0.464753061,0.002435837,0.007526464,Downregulated
Feature0194,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,1,0,0,4,0,0,0,0.8,0.2,2,3.3,6,5,Inf,3,1,Condensed HC,28.04220115,20.27900497,0.723160242,-0.467612731,6.26E-04,0.00330867,Downregulated
Feature0404,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,12,0,0,1,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.333333333,-0.444444444,-10,Carbohydrate,29.0970953,20.95797585,0.720277252,-0.473375753,0.001704711,0.005983398,Downregulated
Feature0508,NA,C16 H28 N2 O13,456.15919,NA,Feature0508,16,28,13,0,0,2,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,27.83084426,20.02814372,0.719638382,-0.474655961,5.25E-07,3.61E-05,Downregulated
Feature0259,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,0,0,0,4,0,0,0,2.8,0,-0.4,71.7,1,1,-3,-3,-3,Other,26.0965856,18.56723885,0.711481538,-0.491101774,0.001214404,0.005098643,Downregulated
Feature0519,NA,C22 H23 N3 O5,431.14036,NA,Feature0519,22,23,5,0,0,3,0,0,0,1.045454545,0.227272727,-0.181818182,65.48181818,13,8,0.357142857,0.454545455,5,Phenol,28.66657786,20.37138125,0.71063178,-0.492825886,1.70E-04,0.001417083,Downregulated
Feature0066,NA,NA,490.12991,NA,Feature0066,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,29.32691497,20.67953354,0.705138388,-0.504021672,5.74E-04,0.003128185,Downregulated
Feature0414,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,5,0,0,6,0,0,0,1.75,0.625,1.75,10.425,5,0,2,7,-6,Amino Sugar,27.68003897,19.41334135,0.70134805,-0.511797523,0.003194278,0.009150277,Downregulated
Feature0465,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,15,0,0,0,0,2,0,1.466666667,0.5,-0.8,83.1,10,-5,-0.538461538,0.024390244,-7,Phenol,28.19050466,19.76395887,0.701085671,-0.512337347,0.001430298,0.005494876,Downregulated
Feature0105,NP-015114 mzCloud,C11 H19 N O6,278.14781,NA,NP-015114 mzCloud,11,19,6,0,0,1,0,0,0,1.727272727,0.545454545,-0.363636364,70.66363636,3,-3,-1,-0.142857143,-4,Protein,26.49955557,18.45086681,0.696270802,-0.52227957,0.001351438,0.005485058,Downregulated
Feature0371,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,7,0,0,1,0,0,0,2.111111111,0.777777778,-0.222222222,66.63333333,1,-6,-7,-0.777777778,-7,Carbohydrate,27.56575663,18.778678,0.68123209,-0.553781699,4.09E-04,0.002508956,Downregulated
Feature0546,NA,C19 H22 Cl2 N6 O,420.12438,NA,Feature0546,20,22,1,0,0,6,2,0,0,1.1,0.05,-0.1,63.15,13,12,0.461538462,0.481481481,6,Unsaturated HC,29.41121881,19.71669724,0.670380149,-0.576948666,5.07E-04,0.002873612,Downregulated
Feature0050,NA,NA,297.08247,NA,Feature0050,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,28.80956856,19.00799364,0.659780573,-0.599941797,3.52E-06,1.21E-04,Downregulated
Feature0189,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,8,0,0,4,0,1,0,1.3,0.8,1,31.8,7,-1,2,-2,-6,Other,29.33356459,19.26586305,0.656785608,-0.606505581,6.39E-05,7.03E-04,Downregulated
Feature0195,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,0,0,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.294117647,2,Lipid,28.91717801,18.68961597,0.646315348,-0.629689843,3.79E-05,5.63E-04,Downregulated
Feature0339,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,7,0,0,0,0,2,0,1.333333333,0.291666667,-1.166666667,93.55,10,3,0.066666667,0.243243243,1,Phenol,27.08777977,17.47261943,0.645036971,-0.632546241,1.03E-04,0.00108325,Downregulated